Vision Is the Art of Seeing the Invisible.”

Seeing the Invisible

2004 ANNUAL REPORT

“Vision is the art of seeing the invisible.”

Jonathan Swift

Our Mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. 2

In 1949, the de Villiers, parents who had lost a child to leukemia, were able to “see” something that existed only in their minds’ eyes: a cure for the disease that took the life of their son. Their vision grew, supported by the belief that only through research of the highest caliber would cures be found. Over the years, exceptional people have shared the de Villiers’ art — the ability to see cures for leukemia, lymphoma and myeloma that only now, more than a half century later, are increasingly visible. The vision of these people, most of them volunteers, has advanced the course of research that has led to longer and better lives for patients battling blood cancers.

This year’s annual report recalls the history of The Leukemia & Lymphoma Society’s vision and celebrates the promise that today’s research holds for blood cancer patients — the hope for a future in which cures for leukemia, lymphoma and myeloma are no longer the purview of the visionary, but are crystal clear for all to see.

Dwayne Howell John Kamins President & CEO Chairman

3 Into the Light

The Society is the world’s leading voluntary health organization ﬁghting blood cancers. The size and scope of its blood cancer research programs are unparalleled in the nonproﬁt sector.

In the mid-1940s, when the de Villiers family lost their son, Robert, to acute leukemia, the only thing known for certain about the disease was that it was fatal. It was a dark time for the distraught family, but the de Villiers were visionaries. They believed that if ignorance took their son, then knowledge was the key to preventing other families from suffering the same loss. They began a new research foundation in 1949, with a small budget and a group of volunteers, and saw a path from their personal darkness into the light.

Today, the organization that grew from that small foundation is a beacon for patients who are fighting leukemia, lymphoma and myeloma. The story of that transformation is inspirational, filled with persistent belief in the possibility of unseen cures and fired by the progress that has been made — the therapeutic innovations, dramatic increases in survival and, more recently, the discovery of targeted drugs that, for some patients, have produced the gift of continuing life.

4 Five-Year Relative Survival Rates: 1960-63 vs. 1995-2000

14% 35% Leukemia 48%

31% 48% Non-Hodgkin Lymphoma 60%

40% 72% Hodgkin Lymphoma The Society ensures the retention 86% of the best scientiﬁc minds 6% 24% Myeloma by systematically increasing 32% the size of grants over time,

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 1960-63 1974-76 giving researchers the resources 1995-2000 Sources:Surveillance, Epidemiology and End Results (SEER) Program 1975-2001, National Cancer Institute, 2004. they need to do their jobs.

Focusing on Results

The de Villiers put the work of their foundation into • Fund basic and clinical research so that new the hands of the world’s best scientific minds. During therapies reach patients as quickly as possible. the late 1940s, the field of medical oncology had yet • Give researchers the support they need to do to emerge, but medicine was moving in that direction, the job. led by discoveries in the study and science of blood. • Use each discovery as a stepping stone to the next, The family recruited a world leader in the field until cures are found. of hematology, Maxwell M. Wintrobe, M.D., Ph.D., who volunteered to help the new foundation develop a research program of the highest quality. As chairman Seeing Ahead of the Curve of the foundation’s Advisory Committee, Dr. Wintrobe convinced others to donate time and expertise to For four decades, the Society grew and flourished, the foundation, beginning a tradition of volunteerism funding research through its Career Development that has been integral to the Society’s track record Program. Discoveries in cancer genetics, immunology of success. and cell biology followed. New treatments were fostered, including advances in chemotherapy and The model developed by the fledgling group still stem cell transplantation — innovations not only exists today, and volunteerism remains its lynchpin: for blood cancers, but also for other types of cancer. • Recruit scientific leaders who volunteer to review By the 1990s, research was evolving and the Society and debate the merits of research projects in foresaw the need for a second research model — one need of funding. that would help provide new therapies for patients • Recommend projects with the highest probability at an accelerated pace. of returning results — advancing our understanding of the mechanisms of blood cancers and developing improved therapies.

5 2004 Research Highlights

The Society’s funding of two new Specialized Center of Research (SCOR) programs this year brings the total of these worldwide centers to 12. This year’s awards went to programs headed by John Bushweller, Ph.D., of the University of Virginia, whose team is developing new drugs to treat chronic myelogenous and acute myelogenous leukemias; and Tak Mak, Ph.D., of the University of Toronto, whose work focuses on understanding the causes of adult and pediatric forms of acute lymphoblastic leukemia.

Scientists on the Society’s National Board of Trustees The Vision Continues worked with Society staff as agents of change; they analyzed the Society’s existing research program With the beginning of the new millennium, and identified new areas in need of funding. They the Society added a third research model. The created a second grant review panel, bringing in fresh Specialized Center of Research (SCOR) program perspectives with the inclusion of clinical researchers. is the first collaborative, multi-disciplinary research What emerged was a research model that was among program dedicated to blood cancer research. the first of its kind: The Translational Research Designed to promote synergy and innovation, Program joined the Society’s Career Development the program offers large, multi-year grants that bring Program, providing funding so that new discoveries basic scientists and translational researchers together in the lab could be tested in clinical trials among to share findings and advance knowledge. In 2004, patients. The concept was so successful that other we are closer than ever to realizing the de Villiers’ organizations followed suit. vision: to bring cures for blood cancer into the light. The Translational Research Program began producing results quickly. One of the first translational researchers was Brian Druker, M.D., whose Society-sponsored research led to the breakthrough drug Gleevec,® the first oral treatment for chronic myelogenous leukemia that kills cancer cells with less harm to normal tissue. Now used to treat three other cancers as well, Gleevec has helped turn certain cancers that might have been fatal into chronic conditions for many patients.

6 Speaking Out

Our advocacy efforts help shine the spotlight on issues important to our constituency — building awareness of the need for legislation to fund research and patient education and assistance programs.

During 2004, the Society helped secure Medicare coverage for oral cancer drugs, such as Gleevec.

The Society also won a $280,000 grant from the Centers for Disease Control and Prevention, for patient support programs. The grant will help the Society provide educational outreach to underserved populations battling leukemia, lymphoma and myeloma. These groups include the elderly, patients with language barriers, racial and ethnic minorities and patients in rural and low- income communities.

As of this ﬁscal year, the Society has more than 16,000 advocates helping us ﬁght for cures.

7 For One Brief Shining Moment

8 For the last three years of her life, Patricia (Trish) Greene, Ph.D., R.N., worked as senior vice president, Patient Services, for The Leukemia & Lymphoma Society. Trish came to the Society with a passion for, and a history of, providing cancer patients with compassionate, individualized care. Tragically, her new job coincided with a diagnosis of pancreatic cancer.

Trish knew her tenure with the Society would be brief, serve these children and their families. As the but she was determined to leave behind changes that prognosis for children with cancer improved, Trish would affect the lives of patients fighting blood cancers saw another critical juncture for young patients. for years to come. And she did just that. She took the Society’s basic back-to-school program and transformed it into an informational resource Trish studied the different junctures during a cancer to help ease the transition of children returning patient’s experience when intervention can make the to school after treatment. Now named in her honor, greatest impact on outcome. She believed that the The Trish Greene Back to School Program for the time immediately following diagnosis was a point at Child with Cancer is a resource for young cancer which access to information and resources was crucial. patients across the country. Trish’s vision and leadership resulted in the creation of the Society’s Information Resource Center (IRC), Trish died in August 1999. A colleague said of her, which has been in contact with more than 200,000 “She might have left us sooner, but she was always patients and family members since its inception focused on the finish line. Before she died, she made in 1997. In keeping with Trish’s beliefs, the IRC’s sure she finished what she had started.” staff of master’s level nurses and social workers Trish’s vision transformed the Society. Her legacy provides individualized answers to each caller. shines on. Trish was also very involved in pediatric oncology. When she entered the field, most children with cancer died, and many professionals chose less emotionally demanding fields. Not Trish. She was driven to

9 A Ray of Light

The Leukemia & Lymphoma Society is a ray

of light and hope for more than 712,000 patients

throughout the country with leukemia, lymphoma

and myeloma, from diagnosis throughout their

cancer journey. In ﬁscal year 2004, more than

812,000 patient contacts were made through

our Information Resource Center (IRC), Web site

and 63 chapters.

10 Contact our IRC at 800.955.4572 or visit our Web site, www.LLS.org .

2004 Patient Services Highlights

The IRC provided individualized responses to 55,000 • Meet the Expert on Non-Hodgkin Lymphoma calls and emails in 2004. As an added service this (NHL), supported by a generous, unrestricted year, information specialists are now available on educational grant from Genentech BioOncology our Web site for live chat, Monday to Friday, and Biogen Idec, Inc. to provide basic 10 a.m. to 5 p.m. ET. information on diagnosis, staging, classiﬁciation and risk factors of NHL plus new treatments Thirteen new education programs and updates and future directions. on leukemia, lymphoma and myeloma were presented this year in Webcast and/or teleconference • Cancer: Keys to Survivorship, presented format, and are now archived on our Web site at in cooperation with The National Coalition www.LLS.org . More than 44,000 people participated for Cancer Survivorship, and supported by an in these programs. educational grant from Ortho Biotech Products, L.P. Three modules from the series are available Chapter-based programs, which reached nearly for viewing on our Web site: 25,000 people in 2004, included: www.lls.org/survivorshipeducation • The Cancer Clinical Trials Education Series, • Strategies for Self Improvement designed by the National Cancer Institute to • Working It Out — Your Employment Rights improve access to current, accurate information as a Cancer Survivor about clinical trials to patients, family members • What Cancer Survivors Need to Know About and healthcare professionals. Health Insurance

11 Sail On

Gary Jobson is the consummate sailor: an America’s Cup winner with Ted Turner in 1977, and winner of the Fastnet Race and numerous other world ocean races. Gary is an author, lecturer, broadcaster/producer and ESPN’s sailing analyst. He also serves as national chairman of The Leukemia Cup Regatta. Over 11 years, Gary has helped build that Society program from a single event into an annual sailing and fundraising campaign that now boasts more than 50 Regattas across the nation.

When Gary became a volunteer find sponsors. His drive was with the Society’s Maryland fueled by people he encountered Chapter in 1993, he was not along the way. “At every event,” personally connected to blood he says, “there was always cancers. But he wanted to help someone…” He doesn’t finish because, in his words, “The the sentence. He doesn’t need to. Society was a worthy cause, and Recently, Gary’s relationship with after doing some research, I was the Society took an unexpected impressed by its integrity and the turn. In 2003 he was diagnosed percentage of money actually with lymphoma. Since then, spent on research and services many of the tactics he developed for patients.” He worked with as a storm sailor have helped the chapter to give the failing him ride out this personal storm. Annapolis Regatta a new “reason Following an exceedingly difficult for living” as a cancer fundraiser. series of treatments, Gary’s cancer After that first success, Gary is in remission. We honor his spoke to Society executive vision and determination to find directors all over the country, cures for blood cancers, both encouraging them to start as a volunteer and as a survivor. Regatta programs in their own We look forward to the day when chapters. “And from there,” he Gary will be able to return fully says, “the program took on a life to the dynamic lifestyle he loves, of its own.” Gary’s initiative and we wish him a vibrant future resulted in his recruiting yacht filled with new adventures. clubs and reaching out to sailing contacts and companies to help

2004 Revenue Highlights

Society net revenue this year was $180.2 million, representing School & YouthSM Programs

The Society’s School & Youth an increase of 10 percent over ﬁscal year 2003. Programs give kindergarten through 12th grade students the opportunity to learn the value of community service by raising The Leukemia & Lymphoma Society and the Leukemia Research funds for blood cancer research and services for patients. Fund of Canada executed an agreement under which the Leukemia This year, School & Youth recruited 8 million students from 15,000 schools and collected Research Fund of Canada became an afﬁliate of the Society, nearly $13 million for cancer research and patient services. Since its inception, the programs effective July 1, 2004, and changed its name to The Leukemia & have raised more than $68 million. Lymphoma Society of Canada. Under the terms of the agreement,

services and programs will be extended to the 66,000 blood cancer

patients, and their families, in Canada.

14 Light The Night® Walk

Light The Night is the Society’s annual evening walk and commemoration of lives touched by cancer. It is held every fall in communities across the country.

Light The Night continued its stellar growth with revenue increases of over 27 percent verses the previous year. In ﬁscal year 2004, 150,000 participants walked in the event in 230 communities all over the country.

Team In Training® (TNT)

Team In Training is the world’s largest endurance sports training program. Professional coaches train participants to run or walk a full or half marathon, bike a century (100-mile) ride or participate in a triathlon.

In ﬁscal year 2004, TNT trained 35,000 participants, raising over $85 million. The Society also partnered with Nike to plan The Nike 26.2, A Marathon for Women to Beneﬁt The Leukemia & Lymphoma Society, scheduled for October 2004.

15 Transforming Vision Into Action The Leukemia & Lymphoma Society could not fulfill phenomenal growth of our Specialized Center of its mission without the generosity and vision of our Research (SCOR) program, which has grown since its donors. Like the Society’s founders, our donors are able inception in 2000 to twelve centers around the world to see ahead to a future that holds cures for blood this year. cancers, and they can put their vision into action by We thank the thousands of people who contributed to providing financial support. Throughout our history, the Society this year, although lack of space prevents us the Society has relied on gifts from major donors and from naming each one. The following lists recognize planned gifts from members of our Legacy Circle to donors who have contributed $10,000 or more in fiscal fuel our efforts to find cures and to enhance and year 2004 (July 1, 2003 through June 30, 2004). We are prolong the lives of patients. In particular, individual profoundly grateful to all of you. and family gifts have played a huge roll in the

Research Grants*

Specialized Center of Research 1 James Bowie, PhD • 2002 Wei Gu, PhD • 2002 Fenyong Liu, PhD • 2002 17 University of California at Los Angeles Columbia University University of California at Berkeley Jerry Adams, PhD • 2002 2 Walter & Eliza Hall Institute Randy Brutkiewicz, PhD • 2004 Theodore Jardetzky, PhD • 2002 13 Clifford Lowell, MD, PhD • 2002 of Medical Research Indiana University School of Medicine Northwestern University School The Regents of the University of Medicine of California, San Francisco Irwin Bernstein, MD • 2003 3 Stephen Buratowski, PhD • 2000 Fred Hutchinson Cancer Research Harvard Medical School Jin Jiang, PhD • 2004 Kun Ping Lu, MD, PhD • 1999 Center University of Texas Beth Israel Deaconess Medical Center Anthony Capobianco, PhD • 2002 John Bushweller, PhD • 2005 Wistar Institute Dong-Yan Jin, MD, PhD • 2002 Andreas Matouschek, PhD • 2003 University of Virginia Department University of Hong Kong Northwestern University School of Physiology J. Don Chen, PhD • 2001 of Medicine University of Medicine and Dentistry Craig Jordan, PhD • 2004 Selina Chen-Kiang, PhD • 2001 of New Jersey University of Rochester Dana Matthews, MD • 1999 Weill Medical College of Cornell Fred Hutchinson Cancer Research University Zhijian Chen, PhD • 2003 9 Jae Jung, PhD • 2001 Center University of Texas New England Regional Primate Riccardo Dalla-Favera, MD • 2004 4 Research Center Danesh Moazed, PhD • 2004 Columbia University Genhong Cheng, PhD • 2001 Harvard Medical School University of California at Los Angeles Michelle Kelliher, PhD • 2004 14 Brian Druker, MD • 20015 University of Massachusetts George Mosialos, PhD • 2005 Oregon Health & Science University Karlene Cimprich, PhD • 2005 Medical School Biomedical Sciences Research Center Stanford University School of Medicine James Grifﬁn, MD • 20016 William Kerr, PhD • 2003 15 Matthew O’Connell, PhD • 2001 Dana-Farber Cancer Institute Pamela Correll, PhD • 2003 H. Lee Mofﬁtt Cancer Research Mount Sinai School of Medicine Pennsylvania State University Center Helen Heslop, MD • 2004 David Pellman, MD • 2001 Baylor College of Medicine Patricia Cortes, PhD • 2002 Nigel Killeen, PhD • 2001 Dana-Farber Cancer Institute Mount Sinai School of Medicine The Regents of the University Carl June, MD • 2002 of California, San Francisco Christoph Plass, PhD • 2003 University of Pennsylvania Chris Counter, PhD • 2003 Ohio State University Duke University Medical Center Scott Kogan, MD • 2005 Scott Lowe, PhD • 2004 7 The Regents of the University Ishwar Radhakrishnan, PhD • 2005 Cold Spring Harbor Laboratory George Daley, MD, PhD • 2000 10 of California, San Francisco Northwestern University School Children’s Hospital of Boston of Medicine Tak Mak, PhD • 2005 Anthony Koleske, PhD • 2003 Advanced Medical Discovery James DeGregori, PhD • 2001 Yale University Guy Sauvageau, MD, PhD • 2003 Institute University of Colorado Health University of Montreal Sciences Center Kerry Kornfeld, MD, PhD • 2002 16 Stephen Nimer, MD • 2002 8 Washington University David Seldin, MD, PhD • 2001 Memorial Sloan-Kettering Cancer Wei Du, PhD • 2004 Boston Medical Center Center University of Chicago Stephen Kron, MD, PhD • 2003 University of Chicago David Sharp, PhD • 2005 Michael Eck, MD, PhD • 2003 Albert Einstein College of Medicine Career Development Program: Dana-Farber Cancer Institute Daniel Lew, PhD • 2001 Scholars Duke University Medical Center Ali Shilatifard, PhD • 2002 18 Christine Eischen, PhD • 2005 Saint Louis University School Peter Adams, PhD • 2004 University of Nebraska Medical Center Gustavo Leone, PhD • 2005 of Medicine Fox Chase Cancer Center Ohio State University Xin-Hua Feng, PhD • 2004 Ramesh Shivdasani, MD, PhD • 2001 David Allman, PhD • 2005 Baylor College of Medicine Xin Lin, PhD • 2005 Dana-Farber Cancer Institute University of Pennsylvania University at Buffalo, Margaret Goodell, PhD • 2002 11 State University of New York Tomasz Skorski, MD, PhD, Francisco Asturias, PhD • 2002 Baylor College of Medicine DSC • 2001 Scripps Research Institute Hsiou-Chi Liou, PhD • 2001 Temple University Jonathan Graff, MD, PhD • 2002 12 Weill Medical College Katherine Borden, PhD • 2001 University of Texas of Cornell University Reshma Taneja, PhD • 2003 University of Montreal Mount Sinai School of Medicine

1 The Specialized Center of Research Grant 4 Dr. Riccardo Dalla-Favera is funded by 5 Dr. Brian Druker is funded in part 8 Dr. Steven Nimer is funded in part by Program is supported in part by a generous a generous gift from Friends In Memory of by a generous gift to the Society from the a generous gift to the Society from the John contribution from General Motors. Todd Alan Whitman, Cathy and Scott Zeilinger Bertelsen Family. & Shirley Davies Foundation. Philanthropic Fund, Ruth and Carl Shapiro 2 Dr. Jerry Adams is funded in part by a generous 6 Dr. James Grifﬁn is funded in part 9 Dr. Zhijian Chen is funded by a generous Family Foundation, Lesley Goldwasser and gift from Eli Lilly and Company. by a generous gift to the Society from the gift to the Society from the St. Valentine’s Day Jonathan Plutzik, Deborah and Jeff Briggs, Virginia Sheldon Jerome Foundation. Luncheon & Style Show. 3 Dr. Irwin Bernstein is funded by a generous Tracy and Frank Collins, James F. Egan, James gift to the Society by an anonymous donor and Karen Finkel, Paul and Susan Friedman, 7 Dr. Scott Lowe is funded in part by a generous 10 Dr. George Daley, a Stephen Birnbaum and the F.M.Kirby Foundation. Jonathan and Jeannie Lavine and Family, gift from Integrity Healthcare Services and Scholar, is funded by a generous gift Tom Marano, Jeffrey and Katina Mayer, Valerie Aspinwall & The Reichman Memorial/ to the Society from The Stephen Birnbaum The Edward L. Milstein Foundation, Michael Altschul Foundation. Foundation. and Elin Nierenberg and Family, Daniel and Carol Spina, Joseph S. and Diane H. Steinberg. 17 * The year displayed after each grant represents the ﬁrst year of grant activity. Research Grants continued

William Tansey, PhD • 2002 Career Development Program: Edmund Waller, MD, PhD • 1999 Roberto De Guzman, PhD • 2003 Cold Spring Harbor Laboratory Scholars in Clinical Research Emory University Scripps Research Institute

Michael Teitell, MD, PhD • 2004 19 Maurizio Bendandi, MD, PhD • 2002 Christopher Walsh, MD, PhD • 2001 Laxminarayana Devireddy, University of California at Los Angeles Clinica Universitaria Mount Sinai School of Medicine PhD • 200326 University of Massachusetts Dimitris Thanos, PhD • 2001 Smita Bhatia, MD • 2002 20 Joseph Wiemels, PhD • 2004 22 Medical School Biomedical Sciences Research Center City of Hope National Medical Center The Regents of the University of California, San Francisco Calin Dumitru, MD, PhD • 2002 Michael Thirman, MD • 2003 Ravi Bhatia, MD • 2003 Thomas Jefferson University University of Chicago City of Hope National Medical Center Career Development Program: Patricia Ernst, PhD • 2002 27 David Toczyski, PhD • 2004 Robert Brodsky, MD • 2001 Special Fellows Dana-Farber Cancer Institute The Regents of the University Johns Hopkins Oncology Center of California, San Francisco Manzoor Ahmad, PhD • 2003 Joaquin Espinosa, PhD • 2004 Richard Burt, MD • 1999 National Institute of Allergy University of Colorado at Boulder Toshio Tsukiyama, PhD, DVM • 2003 Northwestern University & Infectious Disease Fred Hutchinson Cancer Research John Farrar, PhD • 2002 Center John Byrd, MD • 2002 21 Laurie Ailles, PhD • 2004 University of Texas Ohio State University Stanford University Jessica Tyler, PhD • 2004 Harold Fisk, PhD • 2003 University of Colorado Health Martin Carroll, MD • 2004 James Bear, PhD • 2002 Ohio State University Sciences Center University of Pennsylvania University of North Carolina at Chapel Hill Casey Fox, PhD • 2005 David Van Vactor, PhD • 2001 Jorge Cortes, MD • 2001 University of Pennsylvania Harvard Medical School University of Texas Ittai Ben-Porath, PhD • 2005 Whitehead Institute Elsa Flores, PhD • 2004 28 David Vaux, PhD • 2000 Glenn Dranoff, MD • 2001 for Biomedical Research Massachusetts Institute of Technology Walter & Eliza Hall Institute Dana-Farber Cancer Institute of Medical Research Kamel Benlagha, PhD • 2003 Maxim Frolov, PhD • 2003 Ephraim Fuchs, MD • 2004 University of Chicago Massachusetts General Hospital Jose Villadangos, PhD • 2005 Johns Hopkins University School Walter & Eliza Hall Institute of Medicine Klara Briknarova, PhD • 2005 Pierre-Henri Gaillard, PhD • 2003 of Medical Research Burnham Institute Scripps Research Institute Steven Gore, MD • 1999 Claire Walczak, PhD • 2002 Johns Hopkins University School Katja Bruckner, PhD • 2004 Xinsheng Gao, PhD • 2004 Indiana University Medical Center of Medicine Harvard Medical School University of Texas Southwestern Medical Center at Dallas Xiaolu Yang, PhD • 2005 Omer Koc, MD • 2002 Aiyang Cheng, PhD • 2004 University of Pennsylvania Case Western Reserve University Yale University School of Medicine Marc Gavin, PhD • 2004 University of Washington Tso-Pang Yao, PhD • 2004 Mary Laughlin, MD • 1999 Hilary Coller, PhD • 2003 23 Duke University Medical Center Case Western Reserve University Fred Hutchinson Cancer Research Felicia Goodrum Flood, PhD • 2004 Center Princeton University Kyoko Yokomori, PhD, DVM • 2001 Jane Liesveld, MD • 1999 University of California at Irvine University of Rochester Sean Conner, PhD • 2005 Vanesa Gottifredi, PhD • 2003 University of Minnesota, Twin Cities Fundacion Instituto Leloir Hongtao Yu, PhD • 2004 Nikhil Munshi, MD • 1999 University of Texas Dana-Farber Cancer Institute Laurent Coscoy, PhD • 2002 24 Karen Haas, PhD • 2005 University of California at Berkeley Duke University Medical Center Weiguo Zhang, PhD • 2005 Owen O’Connor, MD, PhD • 2003 Duke University Medical Center Memorial Sloan-Kettering Cancer Xu-Ming Dai, MD, PhD • 2003 25 Md Haque, PhD • 2004 Center Albert Einstein College of Medicine Indiana University

Aaron Rapoport, MD • 2002 Nika Danial, PhD • 2004 Beate Heissig, MD, PhD • 2004 University of Maryland Dana-Farber Cancer Institute Juntendo University

Jeffrey Taub, MD • 2003 Randall Davis, MD • 2004 Miho Iijima, PhD • 2005 Children’s Hospital of Michigan University of Alabama at Birmingham Johns Hopkins University School of Medicine

11 Dr. Margaret Goodell, a Stephen Birnbaum 14 Dr. Michelle Kelliher is funded in part 17 Dr. Fenyong Liu is funded in part by 20 Dr. Smita Bhatia is funded by a generous Scholar, is funded by a generous gift to the by a generous gift to the Society from the a generous gift to the Society from the Wayne gift to the Society from The Chuck Grifﬁn Society from The Stephen Birnbaum Gold-Diggers, Inc. & Gladys Valley Foundation. Memorial Research Fund. Foundation. 15 Dr. William Kerr is funded by a generous gift 18 Dr. Ali Shilatifard is funded by a generous gift 21 Dr. John Byrd is funded in part by a generous 12 Dr. Jonathon Graff is funded by a generous to the Society from Michele Newman. to the Society from the Ed Heitz Memorial gift to the Society in memory of Andrew C. gift to the Society from the St. Valentine's Day Research Fund. Renz, M.D. 16 Dr. Kerry Kornfeld is funded by a generous gift Luncheon & Style Show. to the Society from the Ed Heitz Memorial 19 Dr. Michael Teitell is funded in part by 22 Dr. Joseph Wiemels is funded by a generous 13 Dr. Theodore Jardetzky is funded in part Research Fund. a generous gift to the Society from Parents gift to the Society from an anonymous donor. by a generous gift to the Society from the Helen Against Leukemia. Brach Foundation and the Mazza Foundation. 18

Irena Ivanovska, PhD • 2005 Sami Malek, MD • 2004 Toni Portis, PhD • 2003 Angela Stoddart, PhD • 2005 Whitehead Institute University of Michigan Medical Center Northwestern University School University of Chicago for Biomedical Research of Medicine Brendan Manning, PhD • 2005 Valery Sudakin, DSC • 2003 Andreas Ivessa, PhD • 2002 29 Harvard School of Public Health Jian Qu, PhD • 2005 Fox Chase Cancer Center Princeton University The Regents of the University Yinghui Mao, PhD • 2005 of California, San Francisco Vinay Tergaonkar, PhD • 2005 Julie Jameson, PhD • 2004 Ludwig Institute for Cancer Research Salk Institute for Biological Studies Scripps Research Institute Yosef Refaeli, PhD • 2003 Alberto Martin, PhD • 2004 National Jewish Medical Research Scott Tibbetts, PhD • 2004 Edith Janssen, PhD • 2005 University of Toronto Center Washington University La Jolla Institute for Allergy and Immunology Bernhard Mayr, MD • 2003 Karin Reif, PhD • 2002 Benjamin Turk, PhD • 2003 Universitat Erlangen-Nuernberg The Regents of the University Beth Israel Deaconess Medical Center Sue Jaspersen, PhD • 2005 of California, San Francisco The Regents of the University Brooke McCartney, PhD • 2002 Takehiko Usui, PhD • 2005 of Colorado Carnegie Mellon University Gary Reuther, PhD • 2002 Memorial Sloan-Kettering Cancer University of North Carolina Center Janusz Kabarowski, PhD • 2003 Jung-Hyun Min, PhD • 2005 at Chapel Hill University of Alabama at Birmingham Memorial Sloan-Kettering Institute Fred van Leeuwen, PhD • 2004 for Cancer Research Inez Rogatsky, PhD • 2003 Netherlands Cancer Institute Chang Kim, PhD • 2003 Hospital for Special Surgery Purdue University Constantine Mitsiades, MD, Hisse Martien Van Santen, PhD • 2001 PhD • 2004 Joan Roig Amoros, PhD • 2003 Joslin Diabetes Center Alexei Kisselev, PhD • 2002 Dana-Farber Cancer Institute Massachusetts General Hospital Trustees of Dartmouth College Yanchang Wang, PhD • 2002 Sheri Moores, PhD • 2002 Akihide Ryo, MD, PhD • 2003 Florida State University Paul Knoepﬂer, PhD • 2003 Harvard Medical School Yokohama City University Fred Hutchinson Cancer Research Gelin Wang, PhD • 2004 Center Massimo Morra, MD • 2003 Shireen Saleque, PhD • 2004 University of Texas Beth Israel Deaconess Medical Center Children’s Hospital Boston Eric Lai, PhD • 2005 Orion Weiner, PhD • 2005 University of California at Berkeley Raul Mostoslavsky, MD, PhD • 2005 Tomoyuki Sawado, PhD • 2005 Harvard Medical School Children’s Hospital Corporation Fred Hutchinson Cancer Research Yvette Latchman, PhD • 2003 Center Amy Weinmann, PhD • 2004 31 Puget Sound Blood Center and Leon Murphy, PhD • 2004 University of Washington Program Harvard Medical School Jill Schweitzer, PhD • 2004 University of Notre Dame Ting-Ting Wu, PhD • 2002 Isabelle Le Blanc, PhD • 2005 Mikhail Nikiforov, PhD • 2003 University of California at Los Angeles University of California at Berkeley University of Michigan Clare Scott, MD, PhD • 2004 Cold Spring Harbor Laboratory Ping Xie, PhD • 2003 Bin Liu, PhD • 2003 Ryoma Ohi, PhD • 2005 University of Iowa University of California at Los Angeles Harvard Medical School Neil Shah, MD, PhD • 2005 University of California at Los Angeles Jinsong Zhang, PhD • 2004 Cristina Lopez-Rodriguez, PhD • 2001 Joseph Opferman, PhD • 2005 Rockefeller University Fundacio Centre de Regulacio Dana-Farber Cancer Institute David Sherwood, PhD • 2003 Genomica California Institute of Technology Wei-Xing Zong, PhD • 2004 Amir Oryan (Orian), MD, PhD • 2005 University of Pennsylvania Matthew Lorincz, PhD • 2003 Fred Hutchinson Cancer Research Jeffrey Singer, PhD • 2002 Fred Hutchinson Cancer Research Center Brown University Center Career Development Program: Laura Pasqualucci, MD • 2003 Chi Wai So, PhD • 2003 30 Fellows Ana Losada, PhD • 2002 Columbia University Stanford University Cold Spring Harbor Laboratory Joan Adamo, PhD • 2003 Kathrin Plath, PhD • 2005 Eric Spierings, PhD • 2005 Princeton University Hinh Ly, PhD • 2004 Whitehead Institute for Biomedical Leiden University Medical Center Emory University Research David Aiello, PhD • 2005 Walter Steiner, PhD • 2005 University of Massachusetts Niagara University Medical School

23 Dr. Hilary Coller is funded by a generous gift 26 Dr. Laxminarayana Devireddy is funded 29 Dr. Andreas Ivessa is funded by a generous 31 Dr. Amy Weinmann is partially funded to the Society from the Quest for the Cure in part by a generous gift to the Society from gift to the Society from The Karyn Glick by a generous gift to the Society from Research Fund. the Remillard Family Foundation, Inc. Special Fellowship. Northwestern Mutual Life Foundation. 24 Dr. Laurent Coscoy is funded by a gift from 27 Dr. Patricia Ernst is funded by a generous gift 30 Dr. Chi Wai So is funded in part by a generous Delora Sanﬁlippo in memory of Hank Morine, to the Society from the Stobbs Family Quest gift to the Society from The Valley Foundation. Bob Stauffer and Joe Sanﬁlippo. for a Cure. 25 Dr. Xu-Ming Dai is funded in part by 28 Dr. Elsa Flores is funded by a generous a generous gift to the Society from Thomas gift to the Society from the Hildegarde Michael Burke Research Fund. D. Becher Foundation, Inc.

19 Research Grants continued

Dikran Aivazian, PhD • 2003 32 Li-Lin Du, PhD • 2003 Anthony Letai, MD, PhD • 2002 Lily Remsing Rix, PhD • 2005 Stanford University School of Medicine Scripps Research Institute Dana-Farber Cancer Institute Center for Molecular Medicine

Jennifer Antonchuk, PhD • 2004 Dominik Duelli, PhD • 2001 Xiaoling Li, PhD • 2005 Stefan Riedl, PhD • 2005 Walter & Eliza Hall Institute Cold Spring Harbor Laboratory Massachusetts Institute of Technology Princeton University of Medical Research Pinghui Feng, PhD • 2004 Zhe Li, PhD • 2005 Robert Rollins, PhD • 2002 Toshiyuki Araki, PhD • 2003 New England Regional Primate Children’s Hospital Boston Columbia University Beth Israel Deaconess Medical Center Research Center Chinten Lim, PhD • 2005 Adam Rosendorff, MD • 2003 Vladimir Badovinac, PhD • 2002 Sylvia Fischer, PhD • 2005 University of California at San Diego Brigham and Women’s Hospital University of Iowa Massachusetts General Hospital Stephen Lin, PhD • 2005 Karen Ross, PhD • 2002 Peggy Baudouin-Cornu, PhD • 2004 Timothy Fisher, PhD • 2004 Dana-Farber Cancer Institute National Institutes of Health The Mount Sinai Hospital Princeton University Runqing Lu, PhD • 2002 Joseph Scandura, MD, PhD • 2003 35 Michelle Booden, PhD • 2002 James Forrest, PhD • 2005 University of Chicago Memorial Sloan-Kettering Cancer University of North Carolina Emory University Center at Chapel Hill Julian Lum, PhD • 2005 Melanie Foster, PhD • 2002 University of Pennsylvania David Schwartz, PhD • 2003 Douglas Braaten, PhD • 2003 University of California at Berkeley Yale University Washington University Eugene Makeyev, PhD • 2005 Tania Gourley, PhD • 2004 Harvard University Gary Shapiro, PhD • 2005 Benjamin Braun, MD, PhD • 2004 Emory University University of California at San Diego The Regents of the University Vanessa Marsden, PhD • 2005 of California, San Francisco Yuli Guo, PhD • 2003 National Jewish Medical Holger Sondermann, PhD • 2003 36 Dana-Farber Cancer Institute and Research Center University of California at Berkeley Christine Brown, PhD • 2001 City of Hope National Medical Center Jacob Harrison, PhD • 2005 Sebastiaan Meijsing, PhD • 2005 Christian Speck, PhD • 2002 Brandeis University The Regents of the University Cold Spring Harbor Laboratory Deirdre Buckley, PhD • 2004 of California, San Francisco Cold Spring Harbor Laboratory John Hines, PhD • 2003 Vinay Tergaonkar, PhD • 2002 Yale University Shinichi Mizuno, MD, PhD • 2004 Salk Institute for Biological Studies Lynne Bui, MD • 2003 Dana-Farber Cancer Institute University of California at Los Angeles Amy Holdorf, PhD • 2004 Su-Yi Tseng, PhD • 2004 The Mount Sinai Hospital Valerie Notenboom, PhD • 2002 New York University School Isabela Cajiao, MD • 2003 33 Netherlands Cancer Institute of Medicine University of Pennsylvania Kristen Hurov, PhD • 2004 Dana-Farber Cancer Institute Xuewen Pan, PhD • 2004 Lidia Vasilieva, PhD • 2005 Kurt Cannon, PhD • 2002 34 Johns Hopkins University School Harvard Medical School Harvard Medical School Brenda Irvin, PhD • 2003 of Medicine Vanderbilt University Li Wang, PhD • 2004 Giulia Celli, PhD • 2001 Sebastien Pfeffer, PhD • 2005 University of California at Los Angeles Rockefeller University Anna Keating, MD • 2004 Rockefeller University Memorial Sloan-Kettering Cancer Ying-Jie Wang, PhD • 2004 Iris Chan, MD, PhD • 2004 Center Natalie Prigozhina, PhD • 2003 University of Texas Brigham and Women’s Hospital Scripps Research Institute Karen Keeshan, PhD • 2005 David Weinstock, MD • 2005 Jing Chen, PhD • 2005 University of Pennsylvania Philippe Prochasson, PhD • 2004 Memorial Sloan-Kettering Cancer Emory University Stowers Institute for Medical Research Center You-Me Kim, PhD • 2004 Dipanjan Chowdhury, PhD • 2005 Harvard Medical School Ling Qi, PhD • 2003 Richard Willis, PhD • 2004 CBR Institute of Biomedical Salk Institute for Biological Studies National Jewish Medical and Research, Inc. Erica Larschan, PhD • 2005 Research Center Brigham and Women’s Hospital John Randell, PhD • 2004 Kent Christopherson, PhD • 2004 Massachusetts Institute of Technology Niels-Bjarne Woods, PhD • 2005 University of Texas Mathew Lensch, PhD • 2003 Salk Institute for Biological Studies Children’s Hospital Boston Christopher Raymond, PhD • 2003 Zhong Deng, PhD • 2003 Fred Hutchinson Cancer Research Wistar Institute Center

32 Dr. Dikran Aivazian is funded in part by 34 Dr. Kurt Cannon is funded by a generous gift 35 Dr. Joseph Scandura is funded by a generous a generous gift to the Society from the Friends to the Society from the Richard D. Frisbee III gift to the Society from Michael Copley and of Sue Rinsky. Foundation. Leslie Elliot Krause, Esq., in conjunction with Partners in Research. 33 Dr. Isabel Cajiao, the GlaxoSmithKline Gertrude B. Elion Fellow of The Leukemia 36 Dr. Holger Sondermann is funded by & Lymphoma Society, is funded by a generous a generous gift to the Society from Delora endowment from the GlaxoSmithKline Sanﬁlippo in memory of Hank Morine, Foundation and GlaxoSmithKline, Inc. Bob Stauffer and Joe Sanﬁlippo.

20 Jingsong Xu, PhD • 2003 Deborah Banker, PhD • 2002 40 Steven Collins, MD • 2004 42 Francine Foss, MD • 2003 The Regents of the University Fred Hutchinson Cancer Research Fred Hutchinson Cancer Research New England Medical Center of California, San Francisco Center Center Arthur Frankel, MD • 2005 Zheng Xu, PhD • 2005 Dwayne Barber, PhD • 2005 Kenneth Cooke, MD • 2004 Wake Forest University Beth Israel Deaconess Medical Center Ontario Cancer Institute University of Michigan Patricia Fraser, MD • 2001 Tingting Yao, PhD • 2005 Steven Bernstein, MD • 2004 Laurence Cooper, MD, PhD • 2003 43 CBR Institute of Biomedical Stowers Institute for Medical Research University of Rochester City of Hope National Medical Center Research, Inc.

Katherine Zahradka, PhD • 2002 Smita Bhatia, MD • 2002 Richard D’Andrea, PhD • 2004 Arnold Freedman, MD • 2001 Mount Sinai School of Medicine City of Hope National Medical Center Child Health Research Institute Dana-Farber Cancer Institute

Shan Zha, MD, PhD • 2005 Ravi Bhatia, MD • 2003 Bryant Darnay, PhD • 2002 Ephraim Fuchs, MD • 2002 Children’s Hospital Boston City of Hope National Medical Center University of Texas Johns Hopkins University School of Medicine Xiaowu Zhang, PhD • 2003 Bruce Blazar, MD • 2004 Albert Deisseroth, MD, PhD • 2004 Whitehead Institute for Biomedical University of Minnesota Sidney Kimmel Cancer Center Varsha Gandhi, PhD • 2005 Research University of Texas Roger Briesewitz, PhD • 2005 Joseph DiCarlo, MD • 2005 M.D. Anderson Cancer Center Jing Zhang, PhD • 2004 Ohio State University Stanford University Whitehead Institute for Biomedical Spencer Gibson, PhD • 2002 Research Ivan Borrello, MD • 2001 Konstanze Dohner, MD • 2001 University of Manitoba Johns Hopkins University School University of Ulm Fangyi Zhao, PhD • 2003 of Medicine Spencer Gibson, PhD • 2005 University of Minnesota Nicholas Donato, PhD • 2002 University of Manitoba H. Scott Boswell, MD • 2002 University of Texas Song Zhao, MD, PhD • 2005 Indiana University Dwight Gilliland, MD, PhD • 2003 Memorial Sloan-Kettering Cancer Ming-Qing Du, MD, PhD • 2003 Brigham and Women’s Hospital Center John Bushweller, PhD • 2002 University of Cambridge University of Virginia Jianlin Gong, MD • 2004 Rui Zhou, PhD • 2005 Ming-Qing Du, PhD • 2005 Boston University Harvard University John Byrd, MD • 2005 University of Cambridge Ohio State University Steven Gore, MD • 2005 Elizabeth Eklund, MD • 2002 Johns Hopkins University School Translational Research Program Martin Carroll, MD • 2004 Northwestern University School of Medicine University of Pennsylvania of Medicine Vahid Afshar-Kharghan, MD • 2003 37 Stephen Gottschalk, MD • 2004 Baylor College of Medicine Robert Castleberry, MD • 2002 Stephen Emerson, MD, PhD • 2005 Baylor College of Medicine University of Alabama at Birmingham University of Pennsylvania Ricardo Aguiar, MD, PhD • 2002 Steven Grant, MD • 2003 Dana-Farber Cancer Institute Wei Chen, MD, PhD • 2005 Carolyn Felix, MD • 2002 44 Virginia Commonwealth University University of Minnesota The Children’s Hospital of Philadelphia Denis Alexander, PhD • 2003 Ian Harmer, PhD • 2003 Babraham Institute Linzhao Cheng, PhD • 2002 Dean Felsher, MD, PhD • 2004 University of Cambridge Johns Hopkins University School Stanford University School of Medicine Stephen Ansell, MD, PhD • 2004 38 of Medicine Charles Hemenway, MD, PhD • 2005 Mayo Clinic and Foundation Robert Fenton, MD, PhD • 2001 Tulane University School of Medicine Curt Civin, MD • 2001 University of Maryland Scott Armstrong, MD, PhD • 2004 39 Johns Hopkins University School Michael Jensen, MD • 2002 Dana-Farber Cancer Institute of Medicine Adele Fielding, PhD • 2003 City of Hope National Medical Center Mayo Clinic and Foundation David Avigan, MD • 2002 Bayard Clarkson, MD • 2004 Richard Junghans, MD, PhD • 2002 Beth Israel Deaconess Medical Center Memorial Sloan-Kettering Institute for Barry Finette, MD, PhD • 2003 Beth Israel Deaconess Medical Center Cancer Research University of Vermont David Avigan, MD • 2005 Scott Kaufmann, MD, PhD • 2005 Beth Israel Deaconess Medical Center Robert Collins, MD • 2004 41 Richard Ford, MD • 2002 Mayo Clinic and Foundation University of Texas University of Texas Maria Baer, MD • 2003 Thomas Kipps, MD, PhD • 2004 Roswell Park Cancer Institute University of California at San Diego

37 Dr. Vahid Afshar-Kharghan is funded by 39 Dr. Scott Armstrong is funded by a generous 41 Dr. Robert Collins is funded by a generous gift 43 Dr. Laurence Cooper is funded in part by a generous gift from the MPD Foundation gift to the Society from the Connors Family to the Society from the St. Valentine’s Day a generous gift to the Society from The Gail in partnership with Friends of Essential Charitable Fund – Jack and Eileen Connors – Luncheon & Style Show. Cohen Leukemia Fund. Thrombocythemia, Inc. and The Leukemia Willy’s Fund and the William Wesley Kelly 42 Dr. Steven Collins is funded by a generous gift 44 Dr. Carolyn Felix is funded by a generous gift & Lymphoma Society. Research Fund. to the Society from the Quest for the Cure to the Society from the Wipe Out Leukemia 38 Dr. Stephen Ansell is funded in part by 40 Dr. Deborah Banker is funded by a generous Research Fund. Forever Foundation and the Mario Lemieux a generous gift to the Society from Phyllis gift to the Society from The Chuck Grifﬁn Foundation. Rubinstein in honor of Lisa Mulman. Memorial Research Fund.

21 Research Grants continued

Guenther Koehne, MD, PhD • 2001 Mark Minden, MD, PhD • 2003 David Scadden, MD • 2005 Michael Thirman, MD • 2005 Memorial Sloan-Kettering Cancer Ontario Cancer Institute Massachusetts General Hospital University of Chicago Center Shakeel Modak, MD • 2004 46 Aaron Schimmer, MD, PhD • 2004 Michael Tomasson, MD • 2003 55 Marina Konopleva, MD, PhD • 2002 Memorial Sloan-Kettering Cancer Princess Margaret Hospital Washington University University of Texas Center Mathias Schmid, MD • 2001 Max Topp, MD • 2004 Steven Kornblau, MD • 2003 Jeffrey Molldrem, MD • 2002 University Hospital of Ulm, Germany University of Tübingen University of Texas University of Texas Stephen Schuster, MD • 2002 Joseph Tuscano, MD • 2004 Simon Lacey, PhD • 2002 Richard Momparler, PhD • 2001 University of Pennsylvania University of California at Davis Beckman Research Institute Hopital Sainte-Justine Research Center Oliver Semmes, PhD • 2003 Marcel van den Brink, MD, Simon Lacey, PhD • 2005 Benjamin Neel, MD, PhD • 2004 Eastern Virginia Medical School PhD • 2001 Beckman Research Institute Beth Israel Deaconess Medical Center Memorial Sloan-Kettering Cancer Margaret Shipp, MD • 2001 Center Jill Lacy, MD • 2004 Susan Nilsson, PhD • 2004 Dana-Farber Cancer Institute Yale University School of Medicine Peter MacCallum Cancer Centre Andrea Velardi, MD • 2002 56 Judith Shizuru, MD, PhD • 2003 49 Università di Perugia Uma Lakshmipathy, PhD • 2004 Peter Parham, PhD • 2004 47 Stanford University University of Minnesota Stanford University School of Medicine Regis Vilchez, MD • 2003 Sherrill Slichter, MD • 2002 50 Baylor College of Medicine Lawrence Lamb, PhD • 2003 Linda Penn, PhD • 2002 Puget Sound Blood Center and University of Alabama at Birmingham Ontario Cancer Institute Program Ellen Vitetta, PhD • 2001 University of Texas Charles Lee, PhD • 2005 Christoph Plass, PhD • 2005 Florence Smadja, PhD • 2003 Brigham and Women’s Hospital Ohio State University Institut Universitaire d’hématologie Edmund Waller, MD, PhD • 2002 Emory University Jean-Pierre Levesque, PhD • 2001 Miles Prince, MD • 2005 Donald Small, MD, PhD • 2001 Peter MacCallum Cancer Centre Peter MacCallum Cancer Centre Johns Hopkins University Brice Weinberg, MD • 200157 Duke University Medical Center Jane Liesveld, MD • 2004 Louise Purton, PhD • 2003 Donald Small, MD, PhD • 2004 51 University of Rochester Peter MacCallum Cancer Centre Johns Hopkins University Xiao-Feng Yang, MD, PhD • 2004 58 Baylor College of Medicine Hyam Levitsky, MD • 2005 Shahin Raﬁi, MD • 2001 Mitchell Smith, MD, PhD • 2003 52 Johns Hopkins University School Weill Medical College of Cornell Fox Chase Cancer Center Qing Yi, MD, PhD • 2003 of Medicine University University of Texas M.D. Lloyd Stoolman, MD • 2004 Anderson Cancer Center Bing Lim, MD, PhD • 2003 Shahin Raﬁi, MD • 2004 48 University of Michigan Beth Israel Deaconess Medical Center Weill Medical College of Cornell Alice Yu, MD, PhD • 2002 University Alison Stopeck, MD • 2002 University of California at San Diego Ton Logtenberg, PhD • 2001 Arizona Cancer Center University Medical Center Utrecht S. Vincent Rajkumar, MD • 2003 Muxiang Zhou, MD • 2005 Mayo Clinic and Foundation Roger Strair, MD, PhD • 2001 Emory University Jose Lopez, MD • 2005 University of Medicine and Dentistry Baylor College of Medicine Dirk Reinhardt, MD • 2002 of New Jersey Universitätsklinikum Münster Guitta Maki, PhD • 2003 45 Roger Strair, MD, PhD • 200453 Rush University Medical Center Benjamin Rich, PhD • 2001 University of Medicine and Dentistry Brigham and Women’s Hospital of New Jersey Otoniel Martinez-Maza, PhD • 2003 University of California at Los Angeles Alain Rook, MD • 2005 Moshe Talpaz, MD • 2004 University of Pennsylvania University of Texas Hector Martinez-Valdez, MD, PhD • 2003 Cliona Rooney, PhD • 2002 Daniel Tenen, MD • 2001 University of Texas Baylor College of Medicine Beth Israel Deaconess Medical Center

Wilson Miller, MD, PhD • 2003 Peter Rowley, MD • 1997 Helen Tighe, PhD • 2000 54 Jewish General Hospital Lady Davis University of Rochester University of California at San Diego Institute

45 Dr. Guitta Maki is funded in part by 49 Dr. Judith Shizuru is funded by a generous gift 52 Dr. Mitchell Smith is funded by a generous 56 Dr. Andrea Velardi is funded by a generous gift a generous gift to the Society from The to the Society from an anonymous donor. gift to the Society from an anonymous donor. to the Society from an anonymous donor. Coleman Foundation. 50 Dr. Sherrill Slichter is funded by a generous gift 53 Dr. Roger Strair is funded in part by a generous 57 Dr. Brice Weinberg is funded by a generous gift 46 Dr. Shakeel Modak is funded by a generous to the Society from the Quest for the Cure gift to the Society from the John Gallo to the Society from the Jim Jacobs Charitable gift to the Society from an anonymous donor. Research Fund. Charitable Trust. Foundation and the Jim Jacobs Endowment Research Fund. 47 Dr. Peter Parham is funded in part by a gener- 51 Dr. Donald Small is funded by a generous 54 Dr. Helen Tighe is funded by a generous gift ous gift to the Society from Oracle. gift to the Society from the Douglas Kroll to the Society from The Chuck Grifﬁn 58 Dr. Xiao-Feng Yang is funded by a generous Research Program. Memorial Research Fund. gift from the MPD Foundation in partnership 48 Dr. Shahin Raﬁi is funded by a generous with Friends of Essential Thrombocythemia, gift to the Society from the Douglas Kroll 55 Dr. Michael Tomasson is funded by a generous Inc. and The Leukemia & Lymphoma Society. Research Program. gift from Links for Life – Cure Leukemia. 22

Medical and Scientiﬁc Advisors Professional Education Subcommittee

Beverly S. Mitchell, MD, Naomi Rosenberg, PhD † Irwin D. Bernstein, MD, Chair Beverly S. Mitchell, MD (ex ofﬁcio) Chair † Tufts University School of Medicine Fred Hutchinson Cancer Research Lineberger Comprehensive Lineberger Comprehensive Center Cancer Center Cancer Center Margaret A. Shipp, MD † University of North Carolina at University of North Carolina at Dana-Farber Cancer Institute Selina Chen-Kiang, PhD Chapel Hill Chapel Hill Weill Medical College of Cornell Guido J. Tricot, MD, PhD University Joel Rappeport, MD Armand Keating, MD, University of Arkansas Yale University School of Medicine Vice Chair for Medical Sciences Brian Druker, MD Princess Margaret Hospital Howard Hughes Medical Institute Guido J. Tricot, MD, PhD Cheryl L. Willman, MD † Oregon Health & Science University University of Arkansas for Medical Ellin Berman, MD University of New Mexico Cancer Institute Sciences Memorial Sloan-Kettering Cancer Research and Treatment Center Cancer Center James D. Grifﬁn, MD Dana-Farber Cancer Institute David Bodine, PhD National Institutes of Health Judith E. Karp, MD The Sidney Kimmel Cancer Center Selina Chen-Kiang, PhD at Johns Hopkins Weill Medical College of Cornell University Michael L. Long, PhD Velcura Therapeutics, Inc. Curt I. Civin, MD Johns Hopkins Comprehensive Cancer Center

Alan D. D’Andrea, MD Dana-Farber Cancer Institute

Brian Druker, MD † Howard Hughes Medical Institute Endowment Funds Oregon Health & Science University Cancer Institute Charlotte Meyers Research Fund D. Gary Gilliland, MD, PhD Howard Hughes Medical Institute de Villiers Endowment Fund Brigham and Women’s Hospital GlaxoSmithKline Foundation & Richard J. O’Reilly, MD GlaxoSmithKline, Inc. Research Fund Memorial Sloan-Kettering Cancer Center Jim Jacobs Leukemia Research Fund

Warren S. Pear, MD, PhD Mary & Robert Bronstein Abramson Family Cancer Memorial Fund Research Institute Reich Educational Fund Kanti R. Rai, MD Long Island Jewish Medical Center The Rachel Kudish Fund

Joel Rappeport, MD † Yale University School of Medicine The Virginia Major Brooks Memorial Endowment Fund Steven T. Rosen, MD Robert H. Lurie Comprehensive Thomas M. Ford Memorial Fund Cancer Center Vrushali Ranadive Fellowship Fund

† Non-Trustee Committee Member

23 Donors

Research Hollander Family Foundation Daniel J. Cardella Jeffrey Rosen

$1,000,000 and above John & Violaine Bernbach Dave & Gilbert LLP John & Shirley Davies Foundation

Anonymous John Gallo Charitable Trust David M. Crowley Jolliet Energy Resources, Inc.

United Food & Commercial Workers Joseph S. & Diane H. Steinberg DDB Worldwide Communications JWM Partners Group, Inc. International Union (UFCW) Lesley Goldwasser & Jonathan King Street Capital Plutzik Deephaven Capital Management Leslie Elliot Krause, Esq. $500,000 - $999,999 Links for Life Department of Treasury – State of NJ Lionheart Investments, Ltd. Cathy and Scott Zeilinger Local 148 Operating Engineers Dixie Shadow Memorial Fund Philanthropic Fund Lynette Rasmussen MPD Foundation Dubin & Swieca Holdings, Inc. Coen Weddepohl Martha Miller and Emily Lopez Parents Against Leukemia Eagle Trading Systems, Inc Mandell Foundation $100,000 - $499,999 Peter Harman EBF & Associates, LP Mary D. Averbrook Memorial Anonymous Power Corporation of Canada Ed & H Pillsbury Foundation Research Fund

Carl & Ruth Shapiro Family The Karyn Glick Special Fellowship Ed Quinn Mazza Foundation Foundation The Madoff Family Edward & Susan Blumenfeld Mario Lemieux Foundation Cell Therapeutics, Inc. Foundation The Virginia Sheldon Jerome McKenzie Leukemia Fund Douglas Kroll Research Program Foundation Foundation Capital Strategies, Ltd. Michael and Liz Copley Ed Heitz Memorial Research Fund The Wayne & Gladys Valley Foundation Inco Millward Brown, Inc. Foundation F.M. Kirby Foundation Fraternal Order of Eagles and Mr. and Mrs. Art Flaming General Motors Tudor Investment Corporation Ladies Auxiliary, Arizona State Aerie Mr. and Mrs. Daniel Schreiber Helen Santangelo Trust Wipe Out Leukemia Forever Foundation, Inc. Friends In Memory Mr. and Mrs. Gillis Thomas Integrity Healthcare Services of Todd Alan Whitman Mr. and Mrs. Harry Stoddard Michele Newman $10,000 - $49,999 Friends of Essential Mr. and Mrs. Nicholas Maounis Motive Communications, Inc. Algert Coldiron Investors Thrombocythemia, Inc. Mr. Glenn Carlson Quest for the Cure Research Fund AM Investment Partners Gary Kaminsky Northwestern Mutual Life GLS Capital Management St. Valentine’s Day Luncheon AQR Capital Management, LLC Foundation & Style Show Halcyon Alan B. Slifka Management Avenue Capital Management II, LLC Oracle Corporate Giving Program The Bertelsen Family Co. LLC Aviator Fund Management, LP OZ Management, LLC The Jim Jacobs Charitable Ham Ansley Memorial Research Fund Banyon Fund Management, LLC Pam & Keith Kelly Foundation, Inc. Harold Simmons Memorial Golf Barbnet Investment Company Park Place Motorcars Dallas – The Stephen Birnbaum Foundation Helen Brach Foundation Bill and Angie Barrett Lisa and Ken Schnitzer Valerie Aspinwall & The Reichman Imlay Foundation Memorial /Altschul Foundation Bridgewater Associates, Inc. Paula Campese Memorial Fund In memory of Andrew C. Renz, M.D. Windward Homes Canyon Partners Pearl Sellenriek Irwin Gotlieb Carolyn Palavage Pﬁzer, Inc. $100,000 - $499,999 J. Walter Thompson Cathay Financial, LLC Phi Gamma Delta William Wesley Kelly Research Fund Jack and Eileen Connors CIBC World Markets Phyllis Rubinstein James R. Kuse Foundation $50,000 - $99,999 Clarissa & Edgar Bronfman, Jr. PHZ Capital Partners, LP James Resnick Alta M. Guynes Charitable Clyde McGregor and Power Corporation of Canada Jane Elissa/Charlotte Meyers Remainder Trust Joan Kowling McGregor R.G. Niederhoffer Capital Research Fund Delora Sanﬁlippo Cohn & Wolfe Management, Inc. JB Cutting, Inc. Hildegarde D. Becher Foundation, Danford Foundation Ramsey Quantitative Systems Inc. Jeffrey & Katina Mayer Inc. Richard Christopher Stokes

24 Richard E. Salomon Tudor Investment Corporation Boeing Employees Community Fund Auburn University Interfraternity & Laura Landro Salomon Council Two Sigma Investments, LLC Cell Therapeutics, Inc. Rita & Gene Kelly Avy and Marcie Stein U.S. Risk Insurance Group, Inc. – Citigroup Foundation Ronald McDonald House Charities Randall G. Goss BellSouth Employees Community Fund Sigma Alpha Epsilon Fraternity, Walter & Louise Sutcliff Foundation of Boeing Pudget Sound Boeing Houston Employees Fund University of Georgia Walter J. Krissek Family Trust Jeff & Andrea Zimmerman Bruce & Isobel Cleland Simpson, Thacher & Bartlett WAWA Incorporated Lance Armstrong Foundation C. Scott Bruin Sir Martin Sorrell WPP Group USA, Inc. LaRue S. & Walter F. Fischer Canyon Partners, LLC Stanley Shapiro Memorial Trust Wyner-Stokes Foundation Carole Baxter Stark Investments New York State Department Chris Henderson of Health Stephen A. & Christine Bone Marrow CIBC World Markets Schwarzman Pﬁzer, Inc. $10,000 - $49,999 Community Health Charities Sterling Equities Sand Hill Foundation of Kentucky J.P. McCarthy Foundation Sudler & Hennessey The Angels of Charity, Inc. Daniel Lerner Rotary District 5170 Sue Rinsky The Thrasher Trust Dashiell Realty Swing For A Cure The Victor E. and Caroline E. Schutte Dave Anderson Patient Services Foundation – 1959 T.R.G. Management, LP David G. and Diann L. Sant $500,000 - $999,999 The W. O’Neil Foundation Terry and Ron Unkefer Don DeWees Genentech, Inc. WB 33 Kids Fund, A Fund The Blackstone Group of the McCormick Tribune Donald & Sherry Eden The Breeden-Adams Foundation Foundation $100,000 - $499,999 Dr. and Mrs. Richard Raizman The Coleman Foundation Berlex, Inc. Dulé Hill The Edward L. Milstein Foundation Total Program Novartis Pharmaceuticals, Inc. Edgar A. Thornson Foundation The Fludzinski Foundation $100,000 - $499,999 Susan Lang Foundation Edith M. Schweckendieck Trusts The Gail Cohen Leukemia Fund Rush Limbaugh Employees Community Fund $50,000 - $99,999 The Gold-Diggers, Inc. Simon C. Fireman Charitable of Boeing St. Louis Amgen Foundation The Hess Foundation Estate of Frieda Stinemates IDEC The Lightner Sams Foundation, Inc. $50,000 - $99,999 Eugene Hovanec Ilex Oncology The Logos Charitable Fund, Inc. Brian Shaw Fisher Chevrolet-Kia Ortho Biotech Product, LP The Orchard Farm Foundation Carlson Family Foundation Floretine Camenisch Trust Sallie Mae Foundation The Peter Jay Foundation Dr. and Mrs. Irvin B. and Slyvia C. Freddie Hoffman Seagate Technology The Remillard Family Foundation, Braverman Freeman Inc. The Jeff Gordon Foundation Mr. and Mrs. Jim Beck Frightland The Richard D. Frisbee III The Krutz Foundation Pﬁzer, Inc. Garrett Stauffer, CPA Foundation The Victor E. and Caroline E. Schutte The Hearst Foundation, Inc. Genentech, Inc. The Valley Foundation Foundation – Trust E Georgia Classic Rides Thomas Gordon $10,000 - $49,999 $10,000 - $49,999 Georgia Power Foundation Thomas Marano Alabama Council of Association Albertson’s Executives Grassroots Interactive, LLC Thomas Michael Burke Research Fund Annunziata Sanguinetti Foundation Alexandra Mayes Birnbaum Greenberg Traurig LLP

Tony Lefﬁngwell Foundation Arcadia Foundation Aldo Parcesepe Harry & Jeanette Weinberg Foundation, Inc. Tracy & Frank Collins Baxter Health Care Corporation Andrew and Nancy Roach Highmark BlueCross BlueShield Big 33 Scholarship Foundation Anonymous

Donors Sponsor and Promotion Partnerships continued

IKON Ofﬁce Solutions, Inc. Roy Halladay Sponsorships $10,000 - $49,999

In memory of Kent Horth Ruth Bartlett $100,000 - $499,999 A.L. Hanford Memorial Fund

J.T. Tai & Co. Foundation, Inc. Samuel C. Cantor Charitable Trust American Airlines ABM Janitorial Services

Jack J. Kessler, Esq. Sarver Charitable Trust American Bicycle Association Accenture

Janak Amin Stephanie and Randy Imhoff Berlex, Inc. ACCO Brands

Jeremy Connelly Memorial Fund Structured Settlement Finish Line Acordia, Inc.

JMB Hope Foundation Sugar Lakes Foundation Nike ADC

Joan D. Brookhyser The Braman Family Foundation PowerBar Agvar Chemicals, Inc.

Jody and Layton Smith Foundation The Cancer Institute Quality Food Centers Ajmal Kahn/Verus

Joseph Schneller The Edsel and Lorie Dunford Runner’s World Akin, Gump, Strauss, Hauer Charitable Trust & Feld LLP Kim Carney The McGovern Family The Hellis Foundation Alaska Airlines Ladies Aux. Dept. N.J. V.F.W. WYAY EAGLE 106.7 FM The Katten Family (Pam Jam) Alcalde & Fay Lisa Herbert The Kritchman Family Foundation $50,000 - $99,999 Alex. Brown & Sons Charitable Marcia Brady Tucker Foundation Foundation, Inc. The Lebensfeld Foundation 14th Annual San Antonio Golf Mark E. Mason Classic / Bruce Hendin American Management The Max and Victoria Dreyfus Mark Grace Foundation Systems, Inc. Foundation, Inc. Capital Source Mark Zurack & Kathy Ferguson Amgen The Netter Foundation, Inc. Cell Therapeutics, Inc. Menard Family Foundation Anchorage Daily News The Sandra Atlas Bass and DARCARS Merrill Lynch & Co. Edythe & Sol G. Atlas Fund Anheuser Busch Companies Hargrove Inc. Miami Valley Combined The Saylor Foundation Apache Oil IEP/MPG Federal Campaign The Sidney, Milton and Leoma Apfelbaum Family Foundation Mercedes-Benz USA, LLC Michael A. Bannon Foundation Simon Foundation Anteon Corporation Michael McCarthy Foundation Mike and Jeannie O’Neill The Strain Foundation Applied Biosystems Millennium Pharmaceuticals, Inc. Mike Munchak The TJX Companies, Inc. Arnold & Porter LLP Nextel Millennium Pharmaceuticals, Inc. Thomas & Judith Kalen Asprey Regence Blue Cross Blue Shield Moshe Azoulay Verizon AstraZeneca Rudy Project Mr. and Mrs. Richard Post Wyner-Stokes Foundation AT&T Sallie Mae Foundation Mr. and Mrs. Shahan Soghikian National Man & Woman AT&T Business Seagate Technology Mr. and Mrs. Samuel Miller of the Year Aventis Pharmaceuticals SuperGen Mr. and Mrs. Winslow R. Remley Jonathan Smith BAE Systems Sweet ‘N Low/Cumberland Mr. Peter Buttenweiser Jill DiSalvo Packing Corporation Banc of America Securities Ms. E. Ann Remley The Darvish Family Banc of America Securities Ms. Lori Remley Mody North Carolina Toyota Nick and Denni Ferrara Bank of America University Hospitals Health System PaineWebber Foundation (UHHS) Ireland Cancer Center Bank of Tokyo-Mitsubishi

Pilar Bernhardt Foundation, Inc. University Hospitals Health Systems Baxter Health Care Corporation

Raymond Meinke WCNN 680 The Fan AM BearingPoint, Inc.

Rob LaRocque & Carole Clause Bedford Falls Foundation

Robin & Michael Walsh Beers & Cutler

Roger Guillaume Bert Smith & Co.

Sponsorships are institutions or individuals that support a Society event.

26 Big 100 Credit Suisse First Boston Friedman, Billings, Ramsey & Co. Lehman Brothers, Inc.

Biogen Idec Crowe Chizek and Company Fujisawa Linebarger, Goggan, Blair, Pena & Sampson LLP Biosyn, Inc. Cruise Industry Charitable Future Tech Enterprise, Inc. Foundation Lockton Companies Blue Coat Systems, Inc. Gary Martin Hays Danaher Corporation Loomis Fargo Armored Car Service Blue Cross Blue Shield Gemi, LLC of Alabama Danaher Foundation Lunardi’s Markets General Motors, North American Bob Lappin & Gloria Briggs David Mitchell Operations M & T Bank

Bowne & Co., Inc. Decatholon Club Genetech Marriott International

Bristol-Myers Squibb Company Deloitte Genentech BioOncology Masonite International Corporation

Cadbury Schweppes Americas Delta Airlines General Dynamics MCG Capital Corporation Beverages Deutsche Bank Securities, Inc. General Dynamics Wireless Services Medical Mutual Campbell & Company Dewey Ballantine LLP Genta, Inc. Medical Office Properties, Inc. Capital One Services, Inc. Dias Bakery Getz Foundation MedImmune, Inc. Cardinal Health, Inc. Dick & Sally Robinson Google Mellon Carella, Byrne, Bain, Gilfillan, DPR Construction, Inc. N. VA Harkins Builders Merrill Lynch & Co. Cecchi, Stewart & Olstein Dr. Charles Koller HCC Insurance Holdings, Inc. MG JP Morgan Chase Bank Carter’s Dresser Industries Hellwig Plumbing & Heating Michael Baker Corporation CB Richard Ellis Duffy Mechanical HITT Contracting Microsoft Celgene Corporation E•TRADE FINANCIAL Corporation Howrey Simon Arnold Monster Mechanical Cell Therapeutics, Inc. & White LLP EFW, Inc Morgan Lewis Counselors At Law Center Plate NBSE Hoag Memorial Hospital ELG Haniel Metals Corporation Morgan, Lewis & Bockius LLP ChevronTexaco Presbyterian Elizabeth Fago Morgan Stanley Chiron IDEC Enterprise Rent-A-Car Mount Gay Rum Choice Hotels International, Inc. Indianapolis Power Epsilon & Light Company Mr. and Mrs. Bill Smith Christy & Jeffrey Davick, M.D. Ernst & Young LLP Intelsat Global Service Corporation Mr. and Mrs. David Springberg Chrysler Jeep and Dodge ESP-Pharma International Association Muriel McBrien Kauffman Cingular of Heat & Frost Insulation Foundation Ethyl Corporation Clif Bar, Inc. & Asbestos Workers Mylan Foundation Falk Family Foundation, Inc. Citigroup JFK Medical Center National City Fidelity National Title Insurance Clark Construction JP Morgan Company National Cooperative Services Clark Consulting Joshua Bell Corporation (NCSC) FINIS Clear Channel Kaelin Family Captain’s Cup National Rural Utilities Cooperative First Virginia Bank Finance Corporation Comcast K-Designer’s Floors to Go New York Post Computer Associates International, Kaiser Permanente Food Service Management, Inc. North Sails Dominic Abbott Kaiser Permanente Mid Atlantic Corporate Express Northrop Grumman Mission System Foodland Independent Retailers Kitchen & Bath Galleries Corporate Express Business Northwestern Mutual Financial Frank & Susan Witthun KPMG LLP Interiors Network Fred O. Funkhouser Kroger Costco Novartis Pharmaceuticals Freddie Mac KYMX 96.1 Infinity Broadcasting Corporation Cox Communications, Inc. Fried, Frank, Harris, Shriver LaSalle Bank NVR, Inc. Cravath, Swaine & Moore LLP & Jacobson L.E.K Consulting

27 Sponsor and Promotion Partnerships continued

Obsidian Enterprises Inc SBC Communications, Inc. Unisys Corporation Promotions

Oncology Therapeutics Network Scheer Partners, Inc. United Health Care $1,000,000 and above

Openwave Systems, Inc. Schering-Plough University Hospital Dial America Marketing, Inc. OrthoBiotech Scotia Capital University of Pittsburgh Medical Center Oracle Siemens $500,000 - $999,999 USAirways Orlando Magic Sierra Health Foundation KGO Newstalk AM810 Verizon Panera Bread Skyy Verizon Virginia Mason Medical Center Pat Gallagher, PGT Trucking, Inc. Slumberland Furniture $100,000 - $499,999 Volvo of Savannah Paul Hastings Janofsky Smith Barney Burlington Coat Factory & Walker LLP Wachovia Corporation Sprint Computer Associates International, Paymentech Wal-Mart Squire, Sanders & Dempsey Inc. PEPCO Washington Building & Construction St. Joseph’s Hospital of Atlanta Cub Food Stores Trades Council-Charitable Account Pfizer, Inc. St. Joseph’s/Candler Ruth’s Chris Steak House Washington Redskins Leadership Philip S. Contacos, – Baltimore Stempfl Hartke Associates, LLC Council Wachovia Securities The Olive Garden Italian Restaurant SunTrust Bank Waste Management Phillip and Caren Merrick SunTrust Marine Lending Watson Wyatt Worldwide Piper Rudnick LLP $50,000 - $99,999 SuperValu, Pittsburgh, PA Weitz & Luxenberg, P.C. Plumbers & Pipefitters Local A&P Supermarkets Union 72 Suzy Minkoff Wells Fargo CompUSA PNC Advisors Charitable Trust The Bank of New York West Marine $10,000 - $49,999 PNC Bank, Pittsburgh, PA The Brown Family Westin Santa Clara 1190 KEX Polen Family Philanthropic Fund The Cleveland Clinic Foundation Williams & Connolly LLP American Airlines Polk County The Children's Charities Foundation Williams & Russell Building Co. Amerimax Powell Electrical Manufacturing, Inc., The Comprehensive Cancer Center Wilmer, Cutler & Pickering A Division of Powell Industries at Rhode Island Hospital/Hasbro Bowne & Co, Inc. XM Satellite Radio Children’s Hospital/The Miriam Prairie Meadows Racetrack California-Nevada Operating Hospital and Newport Hospital Y92.5 Clear Channel and Casino Engineers Communications The Crean Foundation Precision Communications Coinstar Yellow Corporation The Humana Foundation and Preferred Health Systems Comcast Cable Humana, Inc. PreList America, Inc. Don and Sally Cameron The Meltzer Group Price Modern Donna’s Ride Eight, The Mills Corporation Buckminn’s Harley-Davidsons PricewaterhouseCoopers The Moorings Energy2Cure “Racing for a Reason” Evernham The Niello Company Motorsports Enterprise Rent-A-Car The Richard & Helen DeVos Radigan & Radigan, Inc. Gander Mountain Foundation Rancho Imports Gore The Rockefeller Foundation Realty Capital Partners James W. Martin High School Thelen Reid & Priest LLP of Herndon, LLC Kacey Aumack Trammell Crow Company Riverside Hospital KPMG LLP Turner Construction Company Rural Telephone Finance Cooperative Luke Dunivant UBS Financial Services, Inc. San Francisco Bay Area Labor Marshall Career Services UBS Investment Bank SAP

Promotions are individuals or institutions that organize an event and donate proceeds to the Society.

28 The Legacy Circle

Morris Levine Key Food Foundation, Hugh Albora Paul and Nancy Clendening Wilma Gottlieb Inc. Peter Alexas Wayne Cope Miss Barbara Grace Mrs. Fields Cookies Bruce Allen Susan Corson Rebecca Ann Grajewski Neiman Marcus Group Fay Allen Dr. Anthony Cortese Ruth Granat F

PNC Advisors Margaret Anderson Marianne Cotter Carol Grandaw Marjorie Anderson Raymond Cox Mr. and Mrs. Forrest Grosvenor Tampa Bay Illustrated Debra Andrade Steve R. Craig Dan and LaDonna Gubitz The Classic Catering People Mr. and Mrs. David Andrews Marilyn J. Crohan Mr. and Mrs. Ken Haller Thomas Sumter Academy James and Eileen Andrews Michelle Cromwell Keith P. Harenda Ultimate Frisbee/Versailles, Kristi Anys Edmund D’Allesio Joan Haratani OH Poultry Festival Lorae P. Aumack Judy Davis Alice Hatch Whole Foods Markets, Inc. Mr. and Mrs. Jay Barrows Dr. and Mrs. Michael L. Dean Pat Hauer John Bashta Carolyn Dee Kathleen Hays, RN, MSN Angelo Bardi David and Connie Dimling Tom and Wendy Henry Ruth Bartlett Kathy Dirckx Catherine E. Hildreth Claudia and Stephen Barto, Jr. Dorothy Dootson C. Brooks Hoffman Margaret Beers Joel Drake Carol Hogan Dennis Beardsley Harry and Barbara Dunlap Courtney and Robin Hollar Ryan Beagin John Dunn Jeanie Hoover F Mr. and Mrs. Edwin J. Beckley, Jr. Timothy S. Durst Lynn Hoover Steven R. Bender Agnes Dury Beth Hoth Ami Berkowitz J. Stephen Eickert John Harrison Hough Clyde S. Billman Greg Elfers Roy Hovinen Alexandra Mayes Birnbaum Mr. and Mrs. Jeffrey Ellena Dwayne Howell The Stephen Birnbaum Foundation Judith Erickson Heather Hunt Margaret Black Lynne E. Fazzi Dr. Brian Hurley Richard Blond Harold Fennell William Ianniello Christopher Blum F Harvey Fernbach, MD Charles Ingleﬁeld Lori Blum Richard A. Fess Joan Jarrett Sally Blume Helen F. Fisher F Harry and Donna Johnson III Robert H. and Janet Bohannon Thomas L. Fitzpatrick Kristen Johnson James Bolton Mr. and Mrs. James T. Fox Mrs. Darden Jones Mart Bort Leo Frank Dan and Leslie Jordanger William Boyd David Frantze Patricia Kay Irvin B. Braverman, MD Jon Freitag Nathan and Ruthie T. Katz Wilburn Brewer, Jr. F Paul N. Frimmer Michael E. Keefe Judith Arner Brown Roberta Fuhr Mr. and Mrs. Christopher J. Kearns Richard Cahill Nancy Gamble John B. Kelly Mary Carver Albert and Gladys Gardner Michael Kerper Colon B. Carter Anna Maria Gentile Frances Keating Jennifer Caves John A. Geoghegan Annabelle King, MD Robert Charon Richard and Jacqueline Geswell Sue Kinney-Wieland Pasquale R. Cheche Noreen L. Giese T. Corey Kipp Thomas Cheek Heather Girard Monica Klapper David E. Cherry Wade Goehring Karl Koepke Sylvia Clemetson Richard Goldberg Jeff and Teresa Kopietz

The Legacy Circle honors those who have included the Society F Deceased in an estate plan.

29 The Legacy Circle continued

Carmella Kramer Dennis Morris Delora Sanfilippo Michael E. Walsh Mark and Christine Kraemer James Morton Thomas J. Scanlon Dr. Robin Walsh Leslie Elliot Krause Robert J. Moyle David and Barbara Schaefer John E. Walter R. Scott Krizek Frank Mungo Karl Schaeffer Louise Warner Mr. and Mrs. Greg Kulm Suzanne J. Muntzing Ken Scherzer Philip F. Warner Janna LaCock Oscar Muskopf David A. Schick Paul Weiden, MD Janet LaVere Rodman N. Myers Patrick Schmidt Phyllis Weil Susan Laine Robert J. Myette Eugene Schmitt Vicki Weiland John Lamb, Jr. The Honorable Robert H. Newman Deborah Scott-Ensley James A. Weinberg Lon Laneve Robert C. Niles Lorraine Seidel Deborah Weinstein Lucy Lang Edward Nofer III Anne K. Settembrini Paul and Annie Weiss Alan P. Laskin Jason North Maya Shenoy W. Russell Welsh William S. Lear Richard F. Nourie Frank T. Short Mr. and Mrs. John Wempe Diana Lynn Lee Carolyn and Jerry O’Hara Norbert J. Sieber Dr. and Mrs. Stanley A. White Gail M. Lee Edward D. O’Malley Jay and Elaine Silver Carl and Hillary Whitley Joseph Lee Mrs. Harry O’Toole Linda Sims Don Wier Paul L. Lewis Margaret Olmazu Tena Simmons Clara Wood Robert Lindsey George Omiros Irene Skomro Laura B. Worsham Harvey and Linda Litofsky Rosemary Opbroek Rose Slotsky Mr. and Mrs. Douglas Young Geoffrey Lombard Mary J. Oyer Mary-Gail Smith Joseph Yurfest Mr. and Mrs. F.F. Michael Lynch Jacqueline Anne Palmenberg Mr. and Mrs. Robert Smith Thomas and Anne Zak Ida Malena Mr. and Mrs. Paul Paluch Russell D. Smith Mr. and Mrs. Scott Zeilinger Georgia Davidis Malone Rosa Pena Nicoma Sobolewski Katherine Zell-Cherry Maria Maramag Stephen M. Peters Jeffrey and Angela Solomonson Dr. and Mrs. Stanley N. Marks Mr. and Mrs. David L. Pfeifle John C. Sorrell Greg Martin Leslea S. Pidgeon Elda Spano William Martin William Pike James E. Sparkes Mark E. Mason George Pooley Barbara A. Spiegel Joan Maves Larry Pyles Thomas and Joanne Spink Robert and Marnee Maylone David B. and Toni Quinty Mark and Carol Spisak Dorothy McCann Marty Rauch Darrin Sprilczuk F John and Patty McDonald Diane Raymond Carole Stadfield Thomas and Olive McDonald Richard and Kathy Reader Paula and Phillip Stone Marilyn McFadden Helen Doss Reed Brian J. Stumm Sylvia McGovern James Relkin Marcie Summerlin Carolyn E. McKown David Rice F Dolores Swirin Rita Meek, MD Marilyn Richardson Merideth Tall Timothy and Susan Metzer Ernest Riise Stewart Teichman Tina Marie Milligan Selena Rogers Gracie Thompson Suzy Minkoff Judith A. Ross Patricia Trosclair Joshua Mitchell, MD Mrs. Syril Rubin Heather Turnbull Ted Mociun Seth and Carolyn Rudnick Joseph Verdirame, MD Michael and Tammy Moloy Joseph Russell Bert Vignes Dennis F. Moore, MD Kevin R. Ryan Katherine Wageman-Cook Joan Moran Victor and Jacqueline Sacco Mr. and Mrs. Rubin Wallach Mr. and Mrs. Thaddee F. Moreau William H. Sachs Michael WalrathF

F Deceased Members as of June 30, 2004Anonymous (170)

30 Independent Auditors’ Report

Board of Trustees The Leukemia & Lymphoma Society, Inc.:

We have audited the accompanying consolidated statement of financial position of The Leukemia & Lymphoma Society, Inc. (the Society) as of June 30, 2004, and the related consolidated statements of activities, cash flows and functional expenses for the year then ended. These consolidated financial statements are the responsibility of the Society’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audit. The prior year summarized comparative information has been derived from the Society’s 2003 consolidated financial statements and, in our report dated October 6, 2003, we expressed an unqualified opinion on those statements.

We conducted our audit in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of The Leukemia & Lymphoma Society, Inc. as of June 30, 2004, and the changes in its net assets and its cash flows for the year then ended in conformity with accounting principles generally accepted in the United States of America.

October 1, 2004 New York, NY

Consolidated Statement of Financial Position The Leukemia & Lymphoma Society, Inc. June 30, 2004 (with comparative amounts at June 30, 2003) (in thousands)

2004 2003 Assets Cash and cash equivalents $ 22,703 $ 31,694 Accounts receivable 555 382 Legacies and contributions receivable (note 2) 5,347 7,073 Prepaid expenses 4,024 3,437 Investments, at fair value (note 3) 83,653 60,779 Equipment and leasehold improvements, less accumulated depreciation and amortization of $6,289 and $5,087 3,624 3,896

Total assets $ 119,906 $ 107,261

Liabilities and Net Assets Liabilities: Accounts payable and accrued expenses $ 13,039 $ 13,290 Deferred revenue 6,795 5,291 Grants payable (note 4) 46,613 43,702 Total liabilities 66,447 62,283

Net assets: Unrestricted 46,674 38,008 Temporarily restricted (note 7) 4,465 4,786 Permanently restricted (note 7) 2,320 2,184 Total net assets 53,459 44,978

Total liabilities and net assets $ 119,906 $ 107,261

See accompanying notes to consolidated ﬁnancial statements.

Consolidated Statement of Activities The Leukemia & Lymphoma Society, Inc. Year ended June 30, 2004 (with summarized totals for the year ended June 30, 2003) (in thousands)

Temporarily Permanently Total Unrestricted Restricted Restricted 2004 2003 Revenue Campaign contributions $ 198,893 $ 2,183 $ 28 $ 201,104 $ 185,433 Less direct donor beneﬁt costs (28,394) – – (28,394) (27,370) Net campaign contributions 170,499 2,183 28 172,710 158,063 Legacies 2,365 – 97 2,462 2,914 Net interest and dividend income (note 3) 802 39 – 841 1,620 Net increase (decrease) in fair value of investments 3,234 11 11 3,256 (758) Grant refunds 881 – – 881 2,119 Net assets released from restrictions 2,554 (2,554) – – – Total revenue 180,335 (321) 136 180,150 163,958

Expenses (note 8) Program Services: Research 42,899 – – 42,899 41,738 Patient and community service 46,603 – – 46,603 42,030 Public health education 28,540 – – 28,540 26,217 Professional education 9,071 – – 9,071 8,377 Total program services 127,113 – – 127,113 118,362

Supporting Services: Management and general 14,048 – – 14,048 12,029 Fund raising 30,508 – – 30,508 27,431 Total supporting services 44,556 – – 44,556 39,460

Total expenses 171,669 – – 171,669 157,822

Change in net assets 8,666 (321) 136 8,481 6,136

Net Assets Beginning of year 38,008 4,786 2,184 44,978 38,842 End of year $ 46,674 $ 4,465 $ 2,320 $ 53,459 $ 44,978

See accompanying notes to consolidated ﬁnancial statements.

Consolidated Statement of Cash Flows The Leukemia & Lymphoma Society, Inc. Year ended June 30, 2004 (with comparative amounts for the year ended June 30, 2003) (in thousands)

2004 2003 Cash flows from operating activities: Change in net assets $ 8,481 $ 6,136

Adjustments to reconcile change in net assets to net cash provided by operating activities:

Net (increase) decrease in fair value of investments (3,256) 758 Permanently restricted revenue collected (928) (164) Depreciation and amortization 1,209 1,362

Changes in assets and liabilities:

(Increase) decrease in accounts receivable (173) 467 Decrease (increase) in legacies and contributions receivable 1,726 (2,633) (Increase) decrease in prepaid expenses (587) 100 (Decrease) increase in accounts payable and accrued expenses (251) 1,942 Increase in deferred revenue 1,504 637 Increase in grants payable 2,911 3,441 Net cash provided by operating activities 10,636 12,046

Cash flows from investing activities: Purchases of equipment and leasehold improvements (937) (801) Purchases of investments (70,733) (30,724) Sales of investments 51,115 41,381 Net cash (used in) provided by investing activities (20,555) 9,856

Cash flows from financing activities: Permanently restricted revenue collected 928 164 Net cash provided by ﬁnancing activities 928 164

Net (decrease) increase in cash and cash equivalents (8,991) 22,066 Cash and cash equivalents at beginning of year 31,694 9,628

Cash and cash equivalents at end of year $ 22,703 $ 31,694

See accompanying notes to consolidated ﬁnancial statements.

34 Consolidated Statement of Functional Expenses The Leukemia & Lymphoma Society, Inc. Year ended June 30, 2004 (with comparative totals for the year ended June 30, 2003) (in thousands)

Program Services Supporting Services Direct donor Patient and Public ManagementTotal benefit Direct donorcosts community health Professional and Fund Total benefit costs Research service education education Total general raising Total 2004 2003 2004 2003

Awards and grants $41,084 $ – $ – $ – $41,084 $ – $ – $ – $41,084 $40,101 $ – $ – Financial aid to patients – 4,020 – – 4,020 – – – 4,020 3,631 – – Salaries 477 18,855 8,881 3,886 32,099 4,949 6,564 11,513 43,612 40,526 – –

Employee beneﬁts and taxes (note 5) 89 4,124 2,331 954 7,498 1,170 1,915 3,085 10,583 9,250 – – Occupancy 21 2,473 1,429 640 4,563 763 1,097 1,860 6,423 5,880 – – Insurance 9 227 154 50 440 62 148 210 650 606 – – Telephone 15 981 681 165 1,842 212 1,025 1,237 3,079 2,884 – – Travel 28 822 462 207 1,519 252 329 581 2,100 1,883 10,859 11,170 Printing and supplies 134 4,287 5,400 946 10,767 2,557 7,104 9,661 20,428 19,004 5,070 3,887 Equipment rentals and maintenance 9 700 411 178 1,298 217 326 543 1,841 1,585 – – Postage and shipping 54 2,175 3,283 501 6,013 1,124 4,856 5,980 11,993 10,816 – – Meetings 447 1,445 635 257 2,784 296 412 708 3,492 2,952 5,906 5,835 Professional fees 504 5,607 4,335 1,069 11,515 2,183 6,280 8,463 19,978 16,393 2,945 2,792 Miscellaneous 14 455 256 119 844 142 191 333 1,177 949 3,614 3,686 Depreciation and amortization 14 432 282 99 827 121 261 382 1,209 1,362 – –

Total expenses $ 42,899 $ 46,603 $ 28,540 $ 9,071 $127,113 $ 14,048 $ 30,508 $ 44,556 $171,669 $157,822 $ 28,394 $ 27,370

See accompanying notes to consolidated ﬁnancial statements.

Program Services Expenses

36.7% Research 33.7%

29.6% Patient and Community Service 36.7%

Public Health and Professional Education 29.6%

33.7%

35 Notes to Consolidated Financial Statements The Leukemia & Lymphoma Society, Inc. Year ended June 30, 2004 (with comparative amounts as of and for the year ended June 30, 2003)

1. Organization and Significant Accounting Policies Contributions and Deferred Revenue Contributions are recorded as revenue, at their fair value, when Organization received or promised unconditionally. Contributions received The Leukemia & Lymphoma Society, Inc. (the “Society”) is with donor restrictions that limit their use are reported as either a national not-for-profit health agency dedicated to seeking the temporarily or permanently restricted revenue. When a donor cause and eventual cure of leukemia, lymphoma, Hodgkin’s restriction is met through the passage of time or fulfillment disease and myeloma and improving the quality of life of patients of a purpose restriction, temporarily restricted net assets are and their families. The Society’s principal activities, which are reclassified to unrestricted net assets and reported in the statement conducted through its local chapters and the Home Office, of activities as net assets released from restrictions. Temporarily include: awarding research grants; facilitating psychosocial restricted contributions that are received and expended in the support groups; providing financial aid to patients; answering same period are reported as unrestricted contributions. Conditional phone requests for blood-related cancer information made contributions are recognized as revenue when the conditions have to the Society’s Information Resource Center; and disseminating been substantially met. educational information about blood-related cancers in the form of publications, internet sites and symposia sponsorship for both Deferred revenue includes amounts received for special events the medical community and the general public. that will be held subsequent to the fiscal year-end. Tax-Exempt Status Donated Services The Society qualifies as a charitable organization as defined A substantial number of volunteers have made significant by Internal Revenue Code Section 501(c)(3) and, accordingly, contributions of their time to help develop the Society’s programs is exempt from federal income taxes under Internal Revenue and activities. The value of such volunteer services has not been Code Section 501(a). Additionally, since the Society is publicly- reflected in the accompanying consolidated financial statements supported, contributions to the Society qualify for the maximum as it does not meet the criteria for revenue recognition. charitable contribution deduction under the Internal Revenue Cash Equivalents Code. Cash equivalents consist of money market accounts and short-term Principles of Consolidation investments with a maturity of three months or less from date The accompanying consolidated financial statements include of purchase, except for amounts held for long-term purposes the accounts of the Society, which encompasses the Home reported as investments. Office of the Society and its sixty one chapters, as well as its Equipment, Leasehold Improvements and Depreciation not-for-profit affiliates, The Leukemia & Lymphoma Society Equipment and leasehold improvements are recorded at cost, Research Programs, Inc. and The Leukemia & Lymphoma Society if purchased, or at fair value at date of donation, if contributed, Research Foundation. All significant inter-company and intra- and are depreciated or amortized using the straight-line method Society accounts and transactions have been eliminated in over the estimated useful lives of the assets or the terms of the consolidation. leases, if shorter. Net Asset Classifications Estimates To ensure observance of limitations and restrictions placed The preparation of financial statements in conformity with on the use of resources available to the Society, funds that have generally accepted accounting principles requires the Society’s similar characteristics have been classified into three net asset management to make estimates and assumptions that affect the categories as follows: amounts reported in the financial statements and accompanying Unrestricted net assets: Consist of funds that are fully available, notes. Actual results could differ from those estimates. at the discretion of the Board of Trustees, for the Society Summarized Financial Information to utilize in any of its programs or supporting services. The financial statements are presented with 2003 comparative Temporarily restricted net assets: Consist of funds that are information. With respect to the statement of activities, such prior restricted by donors for a specific time period or purpose, year information is not presented by net assets class and, in the as well as amounts relating to term endowment or deferred statement of functional expenses, 2003 expenses by object are giving arrangements in which the funds must be maintained presented in total rather than by functional category. Accordingly, intact over the lifetimes of the donors. such information should be read in conjunction with the Society’s 2003 financial statements from which the summarized information Permanently restricted net assets: Consist of funds that was derived. contain donor-imposed restrictions requiring that the principal be invested in perpetuity and that only the income be used. Income earned on these funds may be unrestricted or temporarily restricted, depending upon the donor-imposed restrictions.

36 2. Legacies and Contributions Receivable 5. Pension Plan

The Society’s legacies and contributions receivable at June 30, 2004 The Society has a noncontributory, deﬁned contribution 403(b) and 2003 consist of unconditional promises to give and legacies for pension plan covering all employees meeting age and service which the underlying wills have been declared valid by the probate requirements. Contributions are based on a percentage of each court and no other conditions are required to be met. Amounts are eligible employee’s salary and years of service. Expense under this scheduled to be received as follows (in thousands): plan aggregated $2,194,000 and $1,749,000 for the years ended

2004 2003 June 30, 2004 and 2003, respectively. Less than one year $ 5,020 $ 5,293 6. Lease Commitments 1 to 5 years 351 1,730 The leases for premises which the Society’s Home Ofﬁce and After 5 years – 132 chapters occupy expire on various dates through September 30, 2012 5,371 7,155 and provide for certain payments subject to escalation and periodic rate increases relating to real estate taxes, operating expenses and Less discount to present value utilities. (discount rate – 5%) (24) (82) The approximate minimum future annual rental commitments are Total $ 5,347 $ 7,073 summarized as follows (in thousands):

Year ended June 30: 3. Investments 2005 $ 5,415 2006 4,824 The following is a summary of investments at June 30, 2004 and 2007 4,137 2003 (in thousands): 2008 3,541 2004 2003 2009 3,067 Cost or Cost or Thereafter 3,853 Donated Fair Donated Fair Value Value Value Value Total $ 24,837

Money market funds $ 24,874 $ 24,874 $ 12,929 $ 12,929 Corporate notes and bonds 12,999 13,027 28,711 29,285 7. Temporarily and Permanently Restricted Net Assets Common stocks and mutual funds 26,853 28,310 20,085 18,083 Temporarily restricted net assets and the income earned on U.S. Government obligations 17,383 17,384 402 424 permanently restricted net assets are available for the following purposes at June 30, 2004 and 2003 (in thousands): Other 58 58 58 58 2004 2003 Total $ 82,167 $ 83,653 $ 62,185 $ 60,779 Temporarily Permanently Temporarily Permanently Restricted Restricted Restricted Restricted

Debt and equity securities are recorded at fair value as determined Research program $ 3,578 $ 2,273 $ 4,075 $ 2,137 by quoted market prices. Mutual funds are recorded at fair value Patient service and using published unit values. Investment expenses of $281,000 bone marrow donor programs 215 – 298 – and $ 275,000 have been netted against interest and dividend income for the years ended June 30, 2004 and 2003, respectively. Professional education program 23 47 21 47 Other programs 649 – 392 –

4. Awards and Grants Total $ 4,465 $ 2,320 $ 4,786 $ 2,184

Awards and grants for research are recognized as expense in the year approved by the Society’s Board of Trustees. Multi-year 8. Joint Costs Allocation grants, which are generally two to ﬁve years in length, are approved on an annual basis and may be terminated at the discretion of the In 2004 and 2003, the Society incurred joint costs for informational Society’s Board of Trustees. In addition to unconditional grants materials and activities that included fund raising appeals as follows payable of $46,613,000 at June 30, 2004, the Society has grant (in thousands): commitments of $ 55,935,000 that are conditioned upon future 2004 2003 events and, accordingly, are not recorded. Fund raising $ 12,225 $ 10,425 Patient and community service 1,446 1,172 Public health education 7,675 6,705 Total $ 21,346 $ 18,302

37 National Leaders

Chairman of the Board David A. Denihan Lynn C. Hoover Virginia S. Morris Vice President Stinson Morrison Hecker, LLP Clyde Hill, WA John M. Kamins Marsh, Inc. Kansas City, MO Partner Los Angeles, CA Rodman N. Myers Honigman Miller Schwartz and Cohn Thomas F. Hunter Of Counsel Detroit, MI Calvin E. Donnelly President & Chief Executive Officer Honigman Miller Schwartz and Cohn Ellicott City, MD Stimulys Detroit, MI Vice Chairman Carrollton, TX Bruce Douglass Deborah R. Nix David Frantze Boulder, CO Charles F. Inglefield Dalzell, SC Stinson, Mag & Fizzell, PC Bay Village, OH Kansas City, MO Brian Druker, MD Jason North Howard Hughes Medical Institute Dan J. Jordanger JSN Consulting Vice Chairman for Medical and Oregon Health & Science University Partner Palm Beach, FL Scientific Affairs Cancer Institute Hunton & Williams Richmond, VA Mary J. Oyer Beverly S. Mitchell, MD Lawrence D. Ellis, MD Northfield, IL University of North Carolina Professor of Medicine Judith E. Karp, MD Medical School University of Pittsburgh Head, Leukemia Program Frederic C. Parvey Lineberger Comprehensive Cancer Center Pittsburgh, PA The Sidney Kimmel Cancer Center Director at Johns Hopkins Alltel Richard A. Fess Baltimore, MD Jacksonville, FL Secretary/Treasurer President Mid-Florida Agencies of Orlando, Inc. Ruth S. Keefe Peter J. Quesenberry, MD Thomas L. Fitzpatrick Longwood, FL Cincinnati, OH Chair, Department of Research Manager of Corporate Credit Roger Williams Medical Center Saint Gobain Corporation Frances M. Fox, RN, MSN John B. Kelly Providence, RI Worcester, MA President Investment Advisor Home Instead Senior Care Capitol Financial Group Joel Rappeport, MD Mt. Laurel, NJ Sacramento, CA National Board of Trustees Woodbridge, CT

Richard Garrison Leslie Elliot Krause, Esq. Martin Rauch Fay Allen President and Owner Law Offices of Leslie Elliot Krause Owner Jeffersonville, IN Advertising Novelty Co., Inc. New York, NY RE/MAX Schoolside REALTORS Washington, DC Cheshire, CT Margaret H. Anderson Marie Lauria, MSW Managing Partner John A. Geoghegan Oncology Social Work Consultant William H. Reimers Anderson, Bryant, Lasky & Winslow, PSC Gellert & Quartararo, PC University of North Carolina Regional Sales Manager Louisville, KY Purchase, NY Chapel Hill, NC Bowman Enterprises, Inc. Raleigh, NC Thomas Behan Alan M. Gewirtz, MD Michael L. Lawson AstraZeneca Stem Cell Biology & Therapeutic Program President Glenn A. Reiner, Esq. Wilmington, DE University of Pennsylvania Cancer Center Lawrence Utilities, LLC Agins, Seigel & Reiner, LLP Philadelphia, PA Indianapolis, IN New York, NY Alexandra Mayes Birnbaum New York, NY Susan Ann J. Glass Michael W. Long, PhD Marcie Rehmar Rogell Richmond, VA President & Chief Executive Officer Community Education Richard L. Bohanon Velcura Therapeutics, Inc. Children’s Hospital Oklahoma City, OK Carter K. Guice, Jr. Ann Arbor, MI Columbus, OH Assistant U.S. Attorney Robert G. Brower, Esq. Eastern District of Louisiana Dennis F. Marco Naomi Rosenberg, PhD Partner New Orleans, LA North Haledon, NJ Professor of Pathology Bodman, Longley & Dahling, LLP Tufts University School of Medicine Detroit, MI Keith P. Harenda W. Stratford May, Jr., MD, PhD Boston, MA President/Owner Director, Shands Cancer Center Robert A. “Spider” Cantley KPH Construction Corporation University of Florida Kevin R. Ryan Fremont, CA Milwaukee, WI Gainesville, FL Yampolsky, Mandeloff, Silver & Co. Philadelphia, PA Paul J. Cienki Thomas R. McDonald Director, Government Accounting Kathleen Hays, RN, MN Marana, AZ Victor Sacco & Internal Control Director, Inpatient Oncology Services Senior Manager of Real Estate General Dynamics Network Systems University of Pittsburgh Cancer Institute Richard H. Michalik Holiday Companies Needham, MA University of Pittsburgh Medical Center Naperville, IL Bloomington, MN Pittsburgh, PA John M. Coffin, PhD I. Wright Moody Donald H. Salsbery Professor of Microbiology Rex Hidle Deloitte & Touche Director of Finance Tufts University School of Medicine San Antonio, TX Houston, TX UFCW Boston, MA Washington, DC Steven L. Hooker Dennis F. Moore, MD, FACP Michael Copley Senior Vice President, Chairman, Hematology-Oncology John Sanders Community Liaison Chief Financial Officer & Treasurer Wichita Clinic President & Chief Executive Officer Children’s Hospital & Health Center The Regence Group Wichita, KS S.W.M., Inc. San Diego, CA Portland, OR St. Louis, MO

The Leukemia & Lymphoma Society Research Foundation

Anne K. Settembrini Ofﬁcers Tom Bertelsen, Director Beavercreek, OH Investment Banker Harry Pearce, President Maya B. Shenoy Of Counsel Andrew Madoff, Director Charlotte, NC Bowman and Brooke Bernard L. Madoff Investment Securities

Margaret A. Shipp, MD Scott Zeilinger, Director John M. Kamins, Vice President Associate Professor of Medicine Kadima Partners, LLC Partner Dana-Farber Cancer Institute Honigman Miller Schwartz and Cohn Boston, MA Chairman Medical Advisory Board The Leukemia & Lymphoma Society Frank T. Short Edward J. Benz, Jr., MD Short Strategy Group, Inc. Beverly S. Mitchell, MD, President, Dana-Farber Cancer Institute Indianapolis, IN Medical Vice President Lineberger Comprehensive Cancer Center Norbert J. Sieber Donald Pinkel, MD University of North Carolina at San Luis Obis Co., CA Executive Vice President Chapel Hill MARC USA Vice Chairman Miami, FL Louis W. Sullivan, MD Medical and Scientiﬁc Affairs President, Morehouse School of Medicine The Leukemia & Lymphoma Society Jay L. Silver Sugar Land, TX E. Donnall Thomas, MD Dwayne Howell, Secretary-Treasurer Member President & Chief Executive Ofﬁcer Robert S. Smith Fred Hutchinson Cancer Research Center The Leukemia & Lymphoma Society Professor of Medicine, Emeritus Dallas, TX University of Washington School Alexandra Mayes Birnbaum, Director of Medicine Thomas R. Snyder Peartree Communications, Inc. Nashville Bank and Trust Nashville, TN

James E. Sparkes Managing Partner Harris Beach, LLP Syracuse, NY Senior Staff James J. Stephanak Publisher The Kalamazoo Gazette Dwayne Howell Government & Legislative Patient Services Kalamazoo, MI President & Chief Executive Officer Affairs Robin Kornhaber, MSW Amanda M. Termuhlen, MD George Dahlman Senior Vice President Field & Human Resources Children’s Hospital Vice President Patient Services Development Columbus, OH Public Policy Hildy Dillon, MPH Ellen Thompson Cynthia Gardner Vice President Executive Vice President Principal Consultant Marketing Communications Patient Services/Disease Programs Innovative People Solutions Field & Human Resources Development & Revenue Development Anaheim Hills, CA Paul Weiss Richard J. Geswell Research & Medical Programs Jon M. Trombetto Senior Vice President Executive Vice President Raymond James & Associates Field Development Revenue & Marketing Marshall A. Lichtman, MD Tampa, FL Executive Vice President Leslie Chambers Nancy Klein Research & Medical Programs William M. Ward, Jr. Senior Vice President Senior Vice President President & Chief Executive Officer Field Development Marketing Communications Alan Kinniburgh, PhD Presbyterian Manors of Mid-America Senior Vice President Greg Elfers Research Administration Wichita, KS Finance, Administration Senior Vice President & Information Technology Cheryl L. Willman, MD Campaign Development Department of Pathology John Walter University of New Mexico Judith Arner Brown Executive Vice President Cancer Research and Treatment Center Vice President & Chief Financial Officer Albuquerque, NM Major & Planned Gifts Finance, Administration & Information Technology Clara C. Wood Organizational Development Bank of Nashville Jimmy Nangle Nashville, TN Senior Vice President Laurence W. Hausner Finance General Manager Judge Robert M. Yacobi Williamsburg, VA Jon R. Lowell Chief Information Officer

39 Chapter Ofﬁces Alphabetical by state

Alabama Southern Florida Chapter Missouri Southern Ohio Chapter Gulf Coast Chapter 3325 Hollywood Boulevard • Suite 400 Gateway Chapter Fourth and Race Towers 100 Chase Park South • Suite 220 Hollywood, FL 33021 77 West Port Plaza • Suite 101 105 West Fourth Street • Suite 400 Birmingham, AL 35244 Telephone: 954.961.3234 St. Louis, MO 63146 Cincinnati, OH 45202 Telephone: 205.989.0098 Telephone: 314.878.0780 Telephone: 513.361.2100 Suncoast Chapter Arizona 13907 NorthDale Mabry Highway • Suite 101 Nebraska Oklahoma Desert Mountain States Chapter Tampa, FL 33618 Nebraska Chapter Oklahoma Chapter 2990 East Northern Avenue • #E-100 Telephone: 813.963.6461 10832 Old Mill Road • Suite 200 500 N Broadway • Suite 250 Phoenix, AZ 85028 Omaha, NE 68154 Oklahoma City, OK 73102 Telephone: 602.788.8622 Georgia Telephone: 402.344.2242 Telephone: 405.943.8888 Georgia Chapter California 2625 Cumberland Parkway • Suite 205 Nevada Oregon Central California Chapter Atlanta, GA 30339 Southern Nevada Chapter Oregon Chapter 470 East Herndon • Suite 102 Telephone: 770 438 6006 6280 South Valley View Blvd Suite 342 9320 SW Barbur Boulevard • Suite 140 Fresno, CA 93720 Las Vegas, NV 89118 Portland, OR 97219 Telephone: 559.435.1482 Illinois Telephone: 702.436.4220 Telephone: 503.245.9866 Illinois Chapter Greater Los Angeles Chapter 651 West Washington Boulevard • Suite 400 New Jersey Pennsylvania 6033 West Century Boulevard • Suite 300 Chicago, IL 60661 Northern New Jersey Chapter Greater Delaware Valley Division Los Angeles, CA 90045 Telephone: 312.651.7350 116 South Euclid Avenue #2 International Plaza • Suite 105 Telephone: 310.216.7600 Westfield, NJ 07090 Philadelphia, PA 19113 Indiana Telephone: 908 654. 9445 Telephone: 610.521.8274 Greater Sacramento Area Chapter Indiana Chapter 4604 Roseville Road • Suite 100 941 East 86th Street • Suite 100 Southern New Jersey-Shore Chapter Central Pennsylvania Chapter North Highlands, CA 95660 Indianapolis, IN 46240 216 Haddon Avenue • Suite 328 800 Corporate Circle • Suite 100 Telephone: 916.348.1793 Telephone: 317.726.2270 Westmont, NJ 08108 Harrisburg, PA 17110 Telephone: 856.869.0200 Telephone: 717.652.6520 Greater San Francisco Bay Area Iowa Chapter Iowa Chapter New Mexico Eastern Pennsylvania Chapter 1390 Market Street • Suite 1200 8033 University Boulevard • Suite A New Mexico/El Paso Chapter #2 International Plaza • Suite 245 San Francisco, CA 94102 Des Moines, IA 50325 3150 Carlisle N.E. • Suite 35 Philadelphia, PA 19113 Telephone: 415.625.1100 Telephone: 515.270.6169 Albuquerque, NM 87110 Telephone: 610.521.8274 Telephone: 505.830.6040 Orange, Riverside & San Bernardino Kansas Western Pennsylvania & 2333 North Broadway • Suite 320 Kansas Chapter New York West Virginia Chapter Santa Ana, CA 92706 Building 1 • Suite 113 New York Metro Division Two Gateway Center Telephone: 714. 881.0610 555 North Woodlawn 475 Park Avenue South • 8th Floor 13 North Wichita, KS 67208 New York, NY 10016 Pittsburgh, PA 15222 San Diego/Hawaii Chapter Telephone: 316.687.2222 Telephone: 212.689.1400 Telephone: 412.395.2873 8575 Gibbs Drive • Suite 26.2 San Diego, CA 92123 Mid-America Chapter Central New York Chapter Rhode Island Telephone: 858.277.1800 6811 West 63rd Street • Suite 202 Learbury Centre Rhode Island Chapter Cloverleaf Building #1 401 North Salina Street 1150 Pontiac Avenue • Suite 1 Silicon Valley & Monterey Bay Area Shawnee Mission, KS 66202 Syracuse, NY 13203 Cranston, RI 02920 675 North First Street • Suite 1100 Telephone: 913.262.1515 Telephone: 315.471.1050 Telephone: 401.943.8888 San Jose, CA 95112 Telephone: 408.271.2873 Kentucky Long Island Chapter South Carolina Kentucky Chapter 555 Broad Hollow Road South Carolina Chapter Colorado 600 East Main Street • Suite 102 Melville, NY 11747 1247 Lake Murray Boulevard Rocky Mountain Chapter Louisville, KY 40202 Telephone: 631.752.8500 Irmo, SC 29063 5353 West Dartmouth Avenue Telephone: 502.584.8490 Telephone: 803.749.4299 Denver, CO 80227 New York City Chapter Telephone: 303.984.2110 Louisiana 475 Park Avenue South • 8th Floor Tennessee Louisiana Chapter New York, NY 10016 Tennessee Chapter Connecticut 3636 South 1-10 Service Road • Suite 304 Telephone: 212.448.9206 404 BNA Drive • Suite 102 Connecticut Chapter Metairie, LA 70001 Nashville, TN 37217 300 Research Parkway • Suite 310 Telephone: 504.837.0945 Upstate New York/Vermont Chapter Telephone: 615.331.2980 Meriden, CT 06450 6 Automation Lane Telephone: 203.379.0445 Maryland Albany, NY 12205 Texas Maryland Chapter Telephone: 518.438.3583 North Texas Chapter Fairfield County CT Chapter 8600 LaSalle Road • Suite 314 8111 LBJ Freeway • Suite 425 25 Third Street • 4th Floor Chester Building Westchester/Hudson Valley Chapter Dallas, TX 75251 Stamford, CT 06905 Baltimore, MD 21286 1311 Mamaroneck Avenue • Suite 330 Telephone: 972.239.0959 Telephone: 203.967.8326 Telephone: 410.825.2500 White Plains, NY 10605 Telephone: 914.949.0084 South/West Texas Chapter Delaware Massachusetts 950 Isom Road • Suite 104 Delaware Chapter Massachusetts Chapter Western New York & San Antonio, TX 78216 100 West 10th Street • Suite 209 495 Old Connecticut Path • Suite 220 Finger Lakes Chapter Telephone: 210.377.1775 Wilmington, DE 19801 Framingham, MA 01701 4053 Maple Road Telephone: 302.661.7300 Telephone: 508.879.5083 Amherst, NY 14226 Texas Gulf Coast Chapter Telephone: 716.834.2578 5005 Mitchelldale • Suite 115 District of Columbia Michigan Houston, TX 77092 National Capital Area Chapter Michigan Chapter North Carolina Telephone: 713.680.8088 5845 Richmond Highway • Suite 800 1421 East Twelve Mile Road • Building A Eastern North Carolina Chapter Alexandria, VA 22303 Madison Heights, MI 48071 Flagship Building Virginia Telephone: 703.960.1100 Telephone: 248.582.2900 4320 Bland Road Virginia Chapter Raleigh, NC 27609 5511 Staples Mill Road • Suite 105 Florida Minnesota Telephone: 919.875.8252 Richmond, VA 23228 Central Florida Chapter Minnesota Chapter Telephone: 804.627.0400 3319 Maguire Boulevard • Suite 101 5217 Wayzata Boulevard • Suite 221 Western North Carolina Chapter Orlando, Fl 32803 St. Louis Park, MN 55416 5950 Fairview Road • Suite 250 Washington Telephone: 407.898.0733 Telephone: 952.545.3309 Charlotte, NC 28210 Washington/Alaska Chapter Telephone: 704.998.5012 530 Dexter Avenue North • Suite 300 Northern Florida Chapter Mississippi Seattle, WA 98109 9143 Phillips Highway • Suite 130 Mississippi Chapter Ohio Telephone: 206.628.0777 Exchange South 405 Fontaine Place • Suite 103 Central Ohio Chapter Jacksonville FL 32256 Ridgeland, MS 39157 2225 City Gate Drive Suite E Wisconsin Telephone: 904 538.0721 Telephone: 601.956.7447 Columbus, OH 43219 Wisconsin Chapter Telephone: 614.476.7194 4125 North 124th Street • Unit A Palm Beach Area Chapter Brookfield, WI 53005 4360 Northlake Boulevard • Suite 109 Northern Ohio Chapter Telephone: 262.790.4701 Palm Beach Gardens, FL 33410 902 Westpoint Parkway Suite 300 Telephone: 561.775.9954 Cleveland, OH 44145 Telephone: 440.617.2873

40 Illustrations: Jon Allen